Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:piroxicam
go back to main search page
Accession:CHEBI:8249 term browser browse the term
Definition:A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide with the exocyclic nitrogen of 2-aminopyridine. A non-steroidal anti-inflammatory drug of the oxicam class, it is used to relieve pain and works by preventing the production of endogenous prostaglandins involved in the mediation of pain, stiffness, tenderness and swelling.
Synonyms:exact_synonym: 4-hydroxy-2-methyl-N-pyridin-2-yl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
 related_synonym: 4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid;   FELDENE;   Formula=C15H13N3O4S;   InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20);   InChIKey=QYSPLQLAKJAUJT-UHFFFAOYSA-N;   Pyroxycam;   SMILES=CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O;   piroxicamum
 xref: CAS:36322-90-4;   DrugBank:DB00554;   Drug_Central:2210;   HMDB:HMDB0014694;   KEGG:C01608;   KEGG:D00127
 xref_mesh: MESH:D010894
 xref: PMID:11142413;   PMID:12154043;   PMID:28166217;   Patent:DE1943265;   Patent:US3591584;   Reaxys:627692;   Wikipedia:Piroxicam


show annotations for term's descendants           Sort by:
piroxicam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aars1 alanyl-tRNA synthetase 1 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of AARS1 mRNA] CTD PMID:21858171 NCBI chr19:55,906,694...55,930,499
Ensembl chr19:55,906,702...55,930,497 		JBrowse link
G Abcd3 ATP binding cassette subfamily D member 3 decreases expression ISO Piroxicam results in decreased expression of ABCD3 mRNA CTD PMID:21858171 NCBI chr 2:212,536,791...212,590,379
Ensembl chr 2:212,536,791...212,590,504 		JBrowse link
G Acadvl acyl-CoA dehydrogenase, very long chain multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ACADVL mRNA CTD PMID:21858171 NCBI chr10:55,231,558...55,236,786
Ensembl chr10:55,231,440...55,236,750 		JBrowse link
G Ackr3 atypical chemokine receptor 3 decreases expression ISO Piroxicam results in decreased expression of ACKR3 mRNA CTD PMID:19192274 NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:98,246,605...98,260,214 		JBrowse link
G Adipor2 adiponectin receptor 2 decreases expression ISO Piroxicam results in decreased expression of ADIPOR2 mRNA CTD PMID:21858171 NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:154,172,567...154,231,666 		JBrowse link
G Adm adrenomedullin increases expression ISO Piroxicam results in increased expression of ADM mRNA CTD PMID:21858171 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371 		JBrowse link
G Adora2a adenosine A2a receptor decreases expression ISO Piroxicam results in decreased expression of ADORA2A mRNA CTD PMID:19192274 NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802 		JBrowse link
G Agfg1 ArfGAP with FG repeats 1 decreases expression ISO Piroxicam results in decreased expression of AGFG1 mRNA CTD PMID:21858171 NCBI chr 9:91,572,962...91,630,688
Ensembl chr 9:91,573,157...91,626,910 		JBrowse link
G Aimp1 aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 decreases expression ISO Piroxicam results in decreased expression of AIMP1 mRNA CTD PMID:21858171 NCBI chr 2:223,825,930...223,849,477
Ensembl chr 2:223,825,931...223,849,994 		JBrowse link
G Ak2 adenylate kinase 2 increases expression ISO Piroxicam results in increased expression of AK2 mRNA CTD PMID:21858171 NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:146,630,445...146,650,610 		JBrowse link
G Akap12 A-kinase anchoring protein 12 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of AKAP12 mRNA] CTD PMID:21858171 NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:43,199,008...43,225,557 		JBrowse link
G Akr7a2 aldo-keto reductase family 7, member A2 decreases expression ISO Piroxicam results in decreased expression of AKR7A2 mRNA CTD PMID:21858171 NCBI chr 5:156,835,589...156,844,127
Ensembl chr 5:156,835,551...156,844,109 		JBrowse link
G Aldh1a3 aldehyde dehydrogenase 1 family, member A3 decreases expression ISO Piroxicam results in decreased expression of ALDH1A3 mRNA CTD PMID:21858171 NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:129,392,516...129,427,777 		JBrowse link
G Amigo2 adhesion molecule with Ig like domain 2 decreases expression ISO Piroxicam results in decreased expression of AMIGO2 mRNA CTD PMID:19192274 NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:130,270,554...130,282,218 		JBrowse link
G Anp32a acidic nuclear phosphoprotein 32 family member A decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of ANP32A mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of ANP32A mRNA] 		CTD PMID:21858171 NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:71,724,531...71,760,922 		JBrowse link
G Anxa10 annexin A10 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ANXA10 mRNA CTD PMID:21858171 NCBI chr16:32,505,025...32,571,961
Ensembl chr16:32,467,126...32,571,961 		JBrowse link
G Aplp2 amyloid beta precursor like protein 2 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of APLP2 mRNA] CTD PMID:21858171 NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:37,857,407...37,920,031 		JBrowse link
G Arc activity-regulated cytoskeleton-associated protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ARC mRNA CTD PMID:21858171 NCBI chr 7:108,444,959...108,448,413
Ensembl chr 7:108,444,692...108,451,220 		JBrowse link
G Arhgef2 Rho/Rac guanine nucleotide exchange factor 2 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ARHGEF2 mRNA] CTD PMID:21858171 NCBI chr 2:176,358,909...176,416,178
Ensembl chr 2:176,358,904...176,417,646 		JBrowse link
G Arl6ip5 ARF like GTPase 6 interacting protein 5 increases expression ISO Piroxicam results in increased expression of ARL6IP5 mRNA CTD PMID:21858171 NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:131,367,289...131,400,130 		JBrowse link
G Asf1a anti-silencing function 1A histone chaperone decreases expression ISO Piroxicam results in decreased expression of ASF1A mRNA CTD PMID:21858171 NCBI chr20:33,436,632...33,451,478
Ensembl chr20:33,436,707...33,449,639 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) increases expression ISO Piroxicam results in increased expression of ASNS mRNA CTD PMID:21858171 NCBI chr 4:36,752,061...36,769,970
Ensembl chr 4:36,751,802...36,776,050 		JBrowse link
G Aspm assembly factor for spindle microtubules multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of ASPM mRNA] CTD PMID:21858171 NCBI chr13:53,625,584...53,674,489
Ensembl chr13:53,625,584...53,674,489 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 decreases expression ISO Piroxicam results in decreased expression of ATAD2 mRNA CTD PMID:21858171 NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:91,523,626...91,566,238 		JBrowse link
G Atf3 activating transcription factor 3 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of ATF3 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATF3 mRNA] 		CTD PMID:21858171 NCBI chr13:105,274,103...105,331,653
Ensembl chr13:105,282,440...105,295,750 		JBrowse link
G Atf4 activating transcription factor 4 decreases expression ISO Piroxicam results in decreased expression of ATF4 mRNA CTD PMID:21858171 NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:113,684,681...113,686,739 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATP1B1 mRNA] CTD PMID:21858171 NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549 		JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 decreases expression ISO Piroxicam results in decreased expression of ATP2A2 mRNA CTD PMID:21858171 NCBI chr12:39,733,519...39,782,942
Ensembl chr12:39,733,458...39,782,934 		JBrowse link
G Atp5mc1 ATP synthase membrane subunit c locus 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ATP5MC1 mRNA CTD PMID:21858171 NCBI chr10:81,520,762...81,523,735
Ensembl chr10:81,520,765...81,523,363 		JBrowse link
G Atp6v1d ATPase H+ transporting V1 subunit D decreases expression ISO Piroxicam results in decreased expression of ATP6V1D mRNA CTD PMID:21858171 NCBI chr 6:103,389,778...103,405,346
Ensembl chr 6:103,389,783...103,405,346 		JBrowse link
G Aurka aurora kinase A decreases expression ISO Piroxicam results in decreased expression of AURKA mRNA CTD PMID:21858171 NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:181,546,742...181,562,771 		JBrowse link
G Avpi1 arginine vasopressin-induced 1 multiple interactions ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of AVPI1 mRNA] CTD PMID:21858171 NCBI chr 1:250,879,530...250,885,448
Ensembl chr 1:250,879,530...250,885,704 		JBrowse link
G Bag5 BAG cochaperone 5 decreases expression ISO Piroxicam results in decreased expression of BAG5 mRNA CTD PMID:21858171 NCBI chr 6:136,589,623...136,593,278
Ensembl chr 6:136,584,741...136,598,492 		JBrowse link
G Bag6 BAG cochaperone 6 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BAG6 mRNA CTD PMID:21858171 NCBI chr20:3,680,607...3,693,329
Ensembl chr20:3,680,607...3,693,329 		JBrowse link
G Bard1 BRCA1 associated RING domain 1 decreases expression ISO Piroxicam results in decreased expression of BARD1 mRNA CTD PMID:21858171 NCBI chr 9:80,069,960...80,144,167
Ensembl chr 9:80,069,960...80,176,873 		JBrowse link
G Baz1a bromodomain adjacent to zinc finger domain, 1A decreases expression ISO Piroxicam results in decreased expression of BAZ1A mRNA CTD PMID:21858171 NCBI chr 6:78,124,872...78,247,672
Ensembl chr 6:78,124,872...78,247,648 		JBrowse link
G Bcar3 BCAR3 adaptor protein, NSP family member decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of BCAR3 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of BCAR3 mRNA] 		CTD PMID:21858171 NCBI chr 2:213,209,907...213,323,305
Ensembl chr 2:213,209,893...213,323,302 		JBrowse link
G Bccip BRCA2 and CDKN1A interacting protein multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of BCCIP mRNA] CTD PMID:21858171 NCBI chr 1:188,512,544...188,524,957
Ensembl chr 1:197,942,190...197,956,378 		JBrowse link
G Bcl2a1 BCL2-related protein A1 decreases expression ISO Piroxicam results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890 		JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BCLAF1 mRNA CTD PMID:21858171 NCBI chr 1:16,904,572...16,937,106
Ensembl chr 1:16,914,118...16,936,801 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of BIRC5 mRNA] CTD PMID:21858171 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155 		JBrowse link
G Bmp2k BMP-2 inducible kinase increases expression ISO Piroxicam results in increased expression of BMP2K mRNA CTD PMID:21858171 NCBI chr14:12,785,169...12,882,676
Ensembl chr14:12,785,169...12,882,657 		JBrowse link
G Brcc3 BRCA1/BRCA2-containing complex subunit 3 decreases expression ISO Piroxicam results in decreased expression of BRCC3 mRNA CTD PMID:21858171 NCBI chr 9:2,073,927...2,076,469
Ensembl chr 9:2,073,184...2,084,185 		JBrowse link
G Brms1 BRMS1, transcriptional repressor and anoikis regulator multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BRMS1 mRNA CTD PMID:21858171 NCBI chr 1:202,345,766...202,355,028
Ensembl chr 1:211,775,095...211,784,410 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression ISO Piroxicam results in decreased expression of BST2 mRNA CTD PMID:19192274 NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,251,847...18,254,967 		JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of BTG1 mRNA] CTD PMID:21858171 NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:33,227,833...33,230,406 		JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of BUB1 mRNA CTD PMID:21858171 NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:135,472,582...135,504,921 		JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of BUB1B mRNA] CTD PMID:21858171 NCBI chr 3:126,017,019...126,069,470
Ensembl chr 3:126,017,045...126,069,796 		JBrowse link
G C1d C1D nuclear receptor corepressor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of C1D mRNA CTD PMID:21858171 NCBI chr14:95,862,550...95,874,796
Ensembl chr14:95,861,978...95,874,796 		JBrowse link
G Cacybp calcyclin binding protein multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CACYBP mRNA] CTD PMID:21858171 NCBI chr13:74,970,917...74,981,298
Ensembl chr13:74,970,923...74,981,505 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CAD mRNA CTD PMID:21858171 NCBI chr 6:31,012,091...31,035,098
Ensembl chr 6:31,012,091...31,035,297 		JBrowse link
G Cadm1 cell adhesion molecule 1 decreases expression ISO Piroxicam results in decreased expression of CADM1 mRNA CTD PMID:21858171 NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:56,744,372...57,080,192 		JBrowse link
G Calm1 calmodulin 1 decreases expression ISO Piroxicam results in decreased expression of CALM1 mRNA CTD PMID:21858171 NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:125,217,246...125,225,381 		JBrowse link
G Cand1 cullin-associated and neddylation-dissociated 1 increases expression ISO Piroxicam results in increased expression of CAND1 mRNA CTD PMID:21858171 NCBI chr 7:56,566,765...56,604,653
Ensembl chr 7:56,551,394...56,604,655 		JBrowse link
G Canx calnexin multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CANX mRNA CTD PMID:21858171 NCBI chr10:35,124,941...35,157,954
Ensembl chr10:35,124,941...35,157,857 		JBrowse link
G Capg capping actin protein, gelsolin like decreases expression ISO Piroxicam results in decreased expression of CAPG mRNA CTD PMID:21858171 NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672 		JBrowse link
G Capn7 calpain 7 decreases expression ISO Piroxicam results in decreased expression of CAPN7 mRNA CTD PMID:21858171 NCBI chr16:6,552,048...6,588,317
Ensembl chr16:6,552,049...6,588,316 		JBrowse link
G Capza2 capping actin protein of muscle Z-line subunit alpha 2 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CAPZA2 mRNA] CTD PMID:21858171 NCBI chr 4:46,944,040...46,979,930
Ensembl chr 4:46,895,701...46,979,938 		JBrowse link
G Cast calpastatin increases expression ISO Piroxicam results in increased expression of CAST mRNA CTD PMID:21858171 NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:5,707,640...5,817,180 		JBrowse link
G Cav1 caveolin 1 decreases expression ISO Piroxicam results in decreased expression of CAV1 mRNA CTD PMID:21858171 NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740 		JBrowse link
G Ccdc85b coiled-coil domain containing 85B increases expression ISO Piroxicam results in increased expression of CCDC85B mRNA CTD PMID:21858171 NCBI chr 1:212,192,979...212,193,994
Ensembl chr 1:212,189,468...212,196,911 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 decreases expression ISO Piroxicam results in decreased expression of CCL20 mRNA; Piroxicam results in decreased expression of CCL20 protein CTD PMID:19192274 NCBI chr 9:91,837,139...91,839,736
Ensembl chr 9:91,836,946...91,839,736 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Piroxicam results in increased expression of CCN1 mRNA CTD PMID:19192274 NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:237,222,432...237,225,883 		JBrowse link
G Ccn2 cellular communication network factor 2 decreases expression ISO Piroxicam results in decreased expression of CCN2 mRNA CTD PMID:21858171 NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:22,621,501...22,624,976 		JBrowse link
G Ccn5 cellular communication network factor 5 increases expression ISO Piroxicam results in increased expression of CCN5 mRNA CTD PMID:19192274 NCBI chr 3:172,910,670...172,922,064
Ensembl chr 3:172,910,681...172,922,062 		JBrowse link
G Ccna2 cyclin A2 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CCNA2 mRNA] CTD PMID:21858171 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CCNB1 mRNA CTD PMID:21858171 NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:33,646,252...33,655,225 		JBrowse link
G Ccnb2 cyclin B2 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CCNB2 mRNA] CTD PMID:21858171 NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:79,968,465...79,981,682 		JBrowse link
G Ccnc cyclin C decreases expression ISO Piroxicam results in decreased expression of CCNC mRNA CTD PMID:21858171 NCBI chr 5:40,063,589...40,081,731
Ensembl chr 5:40,063,623...40,093,370 		JBrowse link
G Ccnd1 cyclin D1 increases expression ISO Piroxicam results in increased expression of CCND1 mRNA CTD PMID:21858171 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810 		JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO Piroxicam results in decreased expression of CCND3 mRNA CTD PMID:21858171 NCBI chr 9:20,891,696...20,987,199
Ensembl chr 9:20,891,704...20,987,033 		JBrowse link
G Cd44 CD44 molecule increases expression ISO Piroxicam results in increased expression of CD44 mRNA CTD PMID:21858171 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) increases expression ISO Piroxicam results in increased expression of CD55 mRNA CTD PMID:21858171 NCBI chr13:44,409,574...44,438,913
Ensembl chr13:44,409,587...44,438,107 		JBrowse link
G Cdc25a cell division cycle 25A decreases expression ISO Piroxicam results in decreased expression of CDC25A mRNA CTD PMID:21858171 NCBI chr 8:118,742,824...118,761,190
Ensembl chr 8:118,742,426...118,761,188 		JBrowse link
G Cdc42 cell division cycle 42 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CDC42 mRNA CTD PMID:21858171 NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:154,839,631...154,876,627 		JBrowse link
G Cdc45 cell division cycle 45 decreases expression ISO Piroxicam results in decreased expression of CDC45 mRNA CTD PMID:21858171 NCBI chr11:95,689,702...95,714,980
Ensembl chr11:95,689,919...95,714,981 		JBrowse link
G Cdc6 cell division cycle 6 increases expression ISO Piroxicam results in increased expression of CDC6 mRNA CTD PMID:21858171 NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241 		JBrowse link
G Cdca3 cell division cycle associated 3 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CDCA3 mRNA] CTD PMID:21858171 NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068 		JBrowse link
G Cdca4 cell division cycle associated 4 increases expression ISO Piroxicam results in increased expression of CDCA4 mRNA CTD PMID:21858171 NCBI chr 6:137,713,390...137,722,652
Ensembl chr 6:137,713,051...137,722,580 		JBrowse link
G Cdca8 cell division cycle associated 8 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CDCA8 mRNA] CTD PMID:21858171 NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CDK1 mRNA] CTD PMID:21858171 NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,265,289...19,280,455 		JBrowse link
G Cdk2 cyclin dependent kinase 2 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of CDK2 mRNA] CTD PMID:21858171 NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
affects localization 		ISO [Cisplatin co-treated with Piroxicam] affects the localization of CDKN1A protein; [Cisplatin co-treated with Piroxicam] results in decreased expression of CDKN1A protein; [Piroxicam co-treated with Cisplatin] results in increased expression of CDKN1A mRNA; CDKN1A results in increased susceptibility to [Cisplatin co-treated with Piroxicam]
Piroxicam affects the localization of CDKN1A protein 		CTD PMID:21858171 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A mRNA]; Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN2A protein] CTD PMID:12189186 NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:109,100,772...109,119,248 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CDKN3 mRNA CTD PMID:21858171 NCBI chr15:22,502,299...22,513,725
Ensembl chr15:22,502,382...22,513,722 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of CEBPB mRNA]
Piroxicam results in decreased expression of CEBPB mRNA 		CTD PMID:21858171 NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:176,816,859...176,838,072 		JBrowse link
G Cebpg CCAAT/enhancer binding protein gamma multiple interactions
increases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CEBPG mRNA]
Piroxicam results in increased expression of CEBPG mRNA 		CTD PMID:21858171 NCBI chr 1:96,820,981...96,829,736
Ensembl chr 1:96,810,214...96,830,283 		JBrowse link
G Cenpa centromere protein A multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CENPA mRNA CTD PMID:21858171 NCBI chr 6:31,420,062...31,431,703 JBrowse link
G Cenpe centromere protein E decreases expression ISO Piroxicam results in decreased expression of CENPE mRNA CTD PMID:21858171 NCBI chr 2:226,310,970...226,369,636
Ensembl chr 2:226,300,798...226,369,636 		JBrowse link
G Cep170 centrosomal protein 170 increases expression ISO Piroxicam results in increased expression of CEP170 mRNA CTD PMID:21858171 NCBI chr13:91,201,808...91,285,990
Ensembl chr13:91,201,808...91,285,990 		JBrowse link
G Cep55 centrosomal protein 55 decreases expression ISO Piroxicam results in decreased expression of CEP55 mRNA CTD PMID:21858171 NCBI chr 1:245,245,272...245,260,835
Ensembl chr 1:245,245,306...245,260,890 		JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CES2 mRNA CTD PMID:21858171 NCBI chr19:49,884,164...49,898,764
Ensembl chr19:49,884,164...49,898,752 		JBrowse link
G Ciz1 CDKN1A interacting zinc finger protein 1 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of CIZ1 mRNA] CTD PMID:21858171 NCBI chr 3:36,055,753...36,071,510
Ensembl chr 3:36,056,370...36,075,192 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of CKS2 mRNA] CTD PMID:21858171 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519 		JBrowse link
G Clcn3 chloride voltage-gated channel 3 decreases expression ISO Piroxicam results in decreased expression of CLCN3 mRNA CTD PMID:21858171 NCBI chr16:34,138,004...34,210,984
Ensembl chr16:34,137,952...34,210,984 		JBrowse link
G Clgn calmegin decreases expression ISO Piroxicam results in decreased expression of CLGN mRNA CTD PMID:19192274 NCBI chr19:41,601,568...41,633,207
Ensembl chr19:41,601,568...41,633,325 		JBrowse link
G Cnn3 calponin 3 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CNN3 mRNA] CTD PMID:21858171 NCBI chr 2:212,203,661...212,234,772
Ensembl chr 2:212,226,640...212,234,815 		JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO Piroxicam results in increased expression of COL1A1 mRNA CTD PMID:19192274 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460 		JBrowse link
G Colec12 collectin sub-family member 12 increases expression ISO Piroxicam results in increased expression of COLEC12 mRNA CTD PMID:19192274 NCBI chr18:1,005,787...1,193,455
Ensembl chr18:1,005,741...1,195,297 		JBrowse link
G Cops3 COP9 signalosome subunit 3 decreases expression ISO Piroxicam results in decreased expression of COPS3 mRNA CTD PMID:21858171 NCBI chr10:45,117,664...45,151,868
Ensembl chr10:45,117,657...45,152,074 		JBrowse link
G Coq8a coenzyme Q8A multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of COQ8A mRNA] CTD PMID:21858171 NCBI chr13:94,436,680...94,465,535
Ensembl chr13:94,436,546...94,463,378 		JBrowse link
G Cpsf1 cleavage and polyadenylation specific factor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of CPSF1 mRNA CTD PMID:21858171 NCBI chr 7:110,200,078...110,210,644
Ensembl chr 7:110,199,066...110,210,644 		JBrowse link
G Cpsf6 cleavage and polyadenylation specific factor 6 decreases expression ISO Piroxicam results in decreased expression of CPSF6 mRNA CTD PMID:21858171 NCBI chr 7:54,798,452...54,887,711
Ensembl chr 7:54,842,490...54,873,998 		JBrowse link
G Crk CRK proto-oncogene, adaptor protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CRK mRNA CTD PMID:21858171 NCBI chr10:61,028,736...61,054,971
Ensembl chr10:61,028,757...61,082,988 		JBrowse link
G Crtc3 CREB regulated transcription coactivator 3 increases expression ISO Piroxicam results in increased expression of CRTC3 mRNA CTD PMID:21858171 NCBI chr 1:143,962,038...144,064,324
Ensembl chr 1:143,962,038...144,064,288 		JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of CSNK1A1 mRNA] CTD PMID:21858171 NCBI chr18:57,285,156...57,320,540
Ensembl chr18:57,287,412...57,320,538 		JBrowse link
G Csnk2a2 casein kinase 2 alpha 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CSNK2A2 mRNA CTD PMID:21858171 NCBI chr19:9,562,340...9,602,136
Ensembl chr19:9,562,321...9,602,136 		JBrowse link
G Ctnnal1 catenin alpha-like 1 decreases expression ISO Piroxicam results in decreased expression of CTNNAL1 mRNA CTD PMID:21858171 NCBI chr 5:76,309,546...76,375,869
Ensembl chr 5:76,309,546...76,364,637 		JBrowse link
G Ctsc cathepsin C decreases expression ISO Piroxicam results in decreased expression of CTSC mRNA CTD PMID:21858171 NCBI chr 1:151,440,860...151,472,430
Ensembl chr 1:151,441,032...151,474,082 		JBrowse link
G Cul4b cullin 4B decreases expression ISO Piroxicam results in decreased expression of CUL4B mRNA CTD PMID:21858171 NCBI chr  X:122,154,332...122,192,299
Ensembl chr  X:122,154,332...122,192,299 		JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 decreases expression ISO Piroxicam results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression
decreases expression 		ISO Piroxicam results in increased expression of CXCL2 mRNA
Piroxicam results in decreased expression of CXCL2 mRNA 		CTD PMID:19192274 PMID:21858171 NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 decreases expression ISO Piroxicam results in decreased expression of CXCL1 mRNA CTD PMID:19192274 NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,571,900...17,573,624 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 decreases expression ISO Piroxicam results in decreased expression of CXCR4 mRNA CTD PMID:19192274 NCBI chr13:42,630,383...42,634,288
Ensembl chr13:42,630,104...42,634,459 		JBrowse link
G Cyb5b cytochrome b5 type B decreases expression ISO Piroxicam results in decreased expression of CYB5B mRNA CTD PMID:21858171 NCBI chr19:51,972,611...52,006,477
Ensembl chr19:51,972,547...52,026,980 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of CYFIP2 mRNA CTD PMID:21858171 NCBI chr10:31,122,653...31,242,440
Ensembl chr10:31,122,653...31,242,440 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 multiple interactions
decreases activity
decreases expression 		ISO Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP19A1 mRNA]
Piroxicam results in decreased activity of CYP19A1 protein
Piroxicam results in decreased expression of CYP19A1 mRNA 		CTD PMID:15964185 PMID:19147701 NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917 		JBrowse link
G Dbf4 DBF4-CDC7 kinase regulatory subunit increases expression
multiple interactions 		ISO Piroxicam results in increased expression of DBF4 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of DBF4 mRNA] 		CTD PMID:21858171 NCBI chr 4:26,631,491...26,656,080
Ensembl chr 4:26,631,514...26,656,562 		JBrowse link
G Dcxr dicarbonyl and L-xylulose reductase decreases expression ISO Piroxicam results in decreased expression of DCXR mRNA CTD PMID:21858171 NCBI chr10:106,504,730...106,506,619 JBrowse link
G Ddb2 damage specific DNA binding protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DDB2 mRNA CTD PMID:21858171 NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:97,640,579...97,664,066 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DDIT3 mRNA] CTD PMID:21858171 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509 		JBrowse link
G Ddx19a DEAD-box helicase 19A decreases expression ISO Piroxicam results in decreased expression of DDX19A mRNA CTD PMID:21858171 NCBI chr19:55,851,854...55,872,209
Ensembl chr19:55,851,854...55,872,209 		JBrowse link
G Ddx39a DExD-box helicase 39A decreases expression ISO Piroxicam results in decreased expression of DDX39A mRNA CTD PMID:21858171 NCBI chr19:41,323,465...41,331,413
Ensembl chr19:41,322,836...41,332,306 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked decreases expression ISO Piroxicam results in decreased expression of DDX3X mRNA CTD PMID:21858171 NCBI chr  X:12,152,346...12,165,983
Ensembl chr  X:12,152,346...12,165,983 		JBrowse link
G Degs1 delta(4)-desaturase, sphingolipid 1 increases expression ISO Piroxicam results in increased expression of DEGS1 mRNA CTD PMID:21858171 NCBI chr13:96,478,645...96,485,302
Ensembl chr13:96,478,646...96,485,302 		JBrowse link
G Dffa DNA fragmentation factor subunit alpha decreases expression ISO Piroxicam results in decreased expression of DFFA mRNA CTD PMID:21858171 NCBI chr 5:164,823,807...164,836,729
Ensembl chr 5:164,823,807...164,836,728 		JBrowse link
G Dhfr dihydrofolate reductase decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of DHFR mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of DHFR mRNA] 		CTD PMID:21858171 NCBI chr 2:25,320,895...25,346,004 JBrowse link
G Dhx9 DExH-box helicase 9 decreases expression ISO Piroxicam results in decreased expression of DHX9 mRNA CTD PMID:21858171 NCBI chr13:68,152,813...68,189,580
Ensembl chr13:68,152,813...68,189,546 		JBrowse link
G Diaph1 diaphanous-related formin 1 decreases expression ISO Piroxicam results in decreased expression of DIAPH1 mRNA CTD PMID:21858171 NCBI chr18:29,920,889...30,020,280
Ensembl chr18:29,920,889...30,020,280 		JBrowse link
G Dlgap5 DLG associated protein 5 increases expression
multiple interactions 		ISO Piroxicam results in increased expression of DLGAP5 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of DLGAP5 mRNA] 		CTD PMID:21858171 NCBI chr15:23,113,678...23,144,281
Ensembl chr15:23,113,678...23,144,176 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of DNAJA1 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of DNAJA1 mRNA] 		CTD PMID:21858171 NCBI chr 5:60,638,404...60,649,315
Ensembl chr 5:60,638,410...60,650,160 		JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 decreases expression ISO Piroxicam results in decreased expression of DNAJB1 mRNA CTD PMID:21858171 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416 		JBrowse link
G Dnajb12 DnaJ heat shock protein family (Hsp40) member B12 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of DNAJB12 mRNA CTD PMID:21858171 NCBI chr20:28,371,180...28,389,390
Ensembl chr20:28,371,199...28,389,389 		JBrowse link
G Dnajb6 DnaJ heat shock protein family (Hsp40) member B6 decreases expression ISO Piroxicam results in decreased expression of DNAJB6 mRNA CTD PMID:21858171 NCBI chr 4:6,010,081...6,232,052
Ensembl chr 4:6,128,070...6,232,005 		JBrowse link
G Dnajc9 DnaJ heat shock protein family (Hsp40) member C9 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of DNAJC9 mRNA] CTD PMID:21858171 NCBI chr15:3,970,843...4,003,009
Ensembl chr15:3,970,114...3,977,304 		JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Piroxicam results in increased expression of DNMT1 mRNA CTD PMID:21858171 NCBI chr 8:27,716,797...27,763,405
Ensembl chr 8:27,716,797...27,763,119 		JBrowse link
G Donson DNA replication fork stabilization factor DONSON multiple interactions
increases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of DONSON mRNA] CTD PMID:21858171 NCBI chr11:44,405,794...44,419,099
Ensembl chr11:44,405,804...44,418,791 		JBrowse link
G Dpm1 dolichyl-phosphate mannosyltransferase subunit 1, catalytic multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DPM1 mRNA CTD PMID:21858171 NCBI chr 3:177,338,855...177,358,398
Ensembl chr 3:177,338,855...177,358,412 		JBrowse link
G Dpp3 dipeptidylpeptidase 3 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DPP3 mRNA] CTD PMID:21858171 NCBI chr 1:211,634,067...211,657,898
Ensembl chr 1:211,634,068...211,658,310 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of DPYD mRNA CTD PMID:21858171 NCBI chr 2:209,293,902...210,159,777
Ensembl chr 2:209,293,929...210,159,778 		JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 decreases expression ISO Piroxicam results in decreased expression of DPYSL2 mRNA CTD PMID:21858171 NCBI chr15:45,181,041...45,287,065
Ensembl chr15:45,181,041...45,287,065 		JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog decreases expression ISO Piroxicam results in decreased expression of DTL mRNA CTD PMID:21858171 NCBI chr13:105,646,908...105,685,921
Ensembl chr13:105,646,908...105,686,174 		JBrowse link
G Dtymk deoxythymidylate kinase multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of DTYMK mRNA] CTD PMID:21858171 NCBI chr 9:101,762,899...101,771,733
Ensembl chr 9:101,762,899...101,774,504 		JBrowse link
G Dusp1 dual specificity phosphatase 1 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of DUSP1 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of DUSP1 mRNA] 		CTD PMID:21858171 NCBI chr10:17,184,853...17,187,646
Ensembl chr10:17,184,823...17,187,644 		JBrowse link
G Dut deoxyuridine triphosphatase multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of DUT mRNA] CTD PMID:21858171 NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:132,952,394...132,964,956 		JBrowse link
G Dync1h1 dynein cytoplasmic 1 heavy chain 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of DYNC1H1 mRNA CTD PMID:21858171 NCBI chr 6:135,436,375...135,502,117
Ensembl chr 6:135,430,750...135,502,116 		JBrowse link
G Ebna1bp2 EBNA1 binding protein 2 decreases expression ISO Piroxicam results in decreased expression of EBNA1BP2 mRNA CTD PMID:21858171 NCBI chr 5:137,433,534...137,438,100
Ensembl chr 5:137,433,226...137,438,637 		JBrowse link
G Ebp EBP, cholestenol delta-isomerase decreases expression ISO Piroxicam results in decreased expression of EBP mRNA CTD PMID:21858171 NCBI chr  X:16,971,372...16,977,782
Ensembl chr  X:16,971,405...16,977,781 		JBrowse link
G Ect2 epithelial cell transforming 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of ECT2 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of ECT2 mRNA] 		CTD PMID:21858171 NCBI chr 2:111,904,522...111,966,786
Ensembl chr 2:111,904,522...111,966,626 		JBrowse link
G Eef1e1 eukaryotic translation elongation factor 1 epsilon 1 decreases expression ISO Piroxicam results in decreased expression of EEF1E1 mRNA CTD PMID:21858171 NCBI chr17:26,354,247...26,364,953
Ensembl chr17:26,354,228...26,370,687 		JBrowse link
G Egfr epidermal growth factor receptor decreases expression
multiple interactions 		ISO
EXP 		Piroxicam results in decreased expression of EGFR mRNA
Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of EGFR protein] 		CTD PMID:15309881 PMID:21858171 NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358 		JBrowse link
G Eid1 EP300 interacting inhibitor of differentiation 1 decreases expression ISO Piroxicam results in decreased expression of EID1 mRNA CTD PMID:21858171 NCBI chr 3:133,376,389...133,378,108
Ensembl chr 3:133,370,474...133,378,434 		JBrowse link
G Eif1ax eukaryotic translation initiation factor 1A, X-linked multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF1AX mRNA] CTD PMID:21858171 NCBI chr  X:39,307,320...39,322,023
Ensembl chr  X:39,307,137...39,322,021 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha decreases expression ISO Piroxicam results in decreased expression of EIF2S1 mRNA CTD PMID:21858171 NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:103,405,788...103,431,649 		JBrowse link
G Eif3j eukaryotic translation initiation factor 3, subunit J decreases expression ISO Piroxicam results in decreased expression of EIF3J mRNA CTD PMID:21858171 NCBI chr 3:129,438,715...129,460,953
Ensembl chr 3:129,438,722...129,462,246 		JBrowse link
G Eif4a2 eukaryotic translation initiation factor 4A2 decreases expression ISO Piroxicam results in decreased expression of EIF4A2 mRNA CTD PMID:21858171 NCBI chr11:91,268,730...91,276,738
Ensembl chr11:91,268,731...91,275,323 		JBrowse link
G Eif4b eukaryotic translation initiation factor 4B multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of EIF4B mRNA CTD PMID:21858171 NCBI chr 7:135,085,259...135,107,054
Ensembl chr 7:135,085,066...135,107,064 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF4E mRNA] CTD PMID:21858171 NCBI chr 2:229,736,309...229,772,628
Ensembl chr 2:229,739,897...229,774,105 		JBrowse link
G Eif4e2 eukaryotic translation initiation factor 4E family member 2 decreases expression ISO Piroxicam results in decreased expression of EIF4E2 mRNA CTD PMID:21858171 NCBI chr 9:95,333,439...95,362,366
Ensembl chr 9:95,333,989...95,362,362 		JBrowse link
G Eif5 eukaryotic translation initiation factor 5 decreases expression ISO Piroxicam results in decreased expression of EIF5 mRNA CTD PMID:21858171 NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:136,407,440...136,418,821 		JBrowse link
G Eif5b eukaryotic translation initiation factor 5B multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of EIF5B mRNA] CTD PMID:21858171 NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:47,718,706...47,778,583 		JBrowse link
G Epas1 endothelial PAS domain protein 1 decreases expression ISO Piroxicam results in decreased expression of EPAS1 mRNA CTD PMID:21858171 NCBI chr 6:13,543,252...13,626,147
Ensembl chr 6:13,544,389...13,624,729 		JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1-like 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of EPB41L2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of EPB41L2 mRNA] 		CTD PMID:21858171 NCBI chr 1:21,682,336...21,857,106
Ensembl chr 1:21,682,335...21,857,105 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ESM1 mRNA] CTD PMID:21858171 NCBI chr 2:46,609,253...46,617,991
Ensembl chr 2:46,609,204...46,617,990 		JBrowse link
G Ewsr1 EWS RNA-binding protein 1 decreases expression ISO Piroxicam results in decreased expression of EWSR1 mRNA CTD PMID:21858171 NCBI chr14:84,179,413...84,208,149
Ensembl chr14:84,179,618...84,208,095 		JBrowse link
G Exoc3 exocyst complex component 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of EXOC3 mRNA CTD PMID:21858171 NCBI chr 1:30,919,871...30,950,624 JBrowse link
G Exosc8 exosome component 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of EXOSC8 mRNA CTD PMID:21858171 NCBI chr 2:141,080,568...141,087,112
Ensembl chr 2:141,080,568...141,087,229 		JBrowse link
G Exosc9 exosome component 9 decreases expression ISO Piroxicam results in decreased expression of EXOSC9 mRNA CTD PMID:21858171 NCBI chr 2:121,344,154...121,355,110
Ensembl chr 2:121,344,175...121,374,232 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit decreases expression ISO Piroxicam results in decreased expression of EZH2 mRNA CTD PMID:21858171 NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:77,624,223...77,687,183 		JBrowse link
G F8a1 coagulation factor VIII-associated 1 decreases expression ISO Piroxicam results in decreased expression of F8A1 mRNA CTD PMID:21858171 NCBI chr  X:155,977,859...155,979,373
Ensembl chr  X:155,976,941...156,108,974 		JBrowse link
G Fam111a FAM111 trypsin like peptidase A increases expression ISO Piroxicam results in increased expression of FAM111A mRNA CTD PMID:21858171 NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:219,065,601...219,081,211 		JBrowse link
G Fanci FA complementation group I increases expression ISO Piroxicam results in increased expression of FANCI mRNA CTD PMID:21858171 NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:142,736,653...142,792,999 		JBrowse link
G Fancl FA complementation group L increases expression ISO Piroxicam results in increased expression of FANCL mRNA CTD PMID:21858171 NCBI chr14:104,449,403...104,515,297
Ensembl chr14:104,394,590...104,515,297 		JBrowse link
G Fbxo9 f-box protein 9 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of FBXO9 mRNA] CTD PMID:21858171 NCBI chr 8:87,838,787...87,864,362
Ensembl chr 8:87,838,789...87,864,504 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of FDFT1 mRNA] CTD PMID:21858171 NCBI chr15:41,588,114...41,616,168
Ensembl chr15:41,588,117...41,616,168 		JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO Piroxicam results in decreased expression of FDPS mRNA CTD PMID:21858171 NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:176,795,192...176,807,136 		JBrowse link
G Fdxr ferredoxin reductase multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FDXR mRNA CTD PMID:21858171 NCBI chr10:101,006,845...101,015,582
Ensembl chr10:101,006,849...101,015,542 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of FEN1 mRNA] CTD PMID:21858171 NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:216,269,163...216,275,016 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of FGF2 mRNA] CTD PMID:21858171 NCBI chr 2:122,164,454...122,218,796
Ensembl chr 2:122,164,454...122,224,493 		JBrowse link
G Flii FLII, actin remodeling protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FLII mRNA CTD PMID:21858171 NCBI chr10:45,893,566...45,907,547
Ensembl chr10:45,893,572...45,907,491 		JBrowse link
G Flnb filamin B decreases expression ISO Piroxicam results in decreased expression of FLNB mRNA CTD PMID:21858171 NCBI chr15:19,392,212...19,525,278
Ensembl chr15:19,392,216...19,525,209 		JBrowse link
G Foxm1 forkhead box M1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of FOXM1 mRNA CTD PMID:21858171 NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:163,325,614...163,337,172 		JBrowse link
G Fst follistatin decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of FST mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of FST mRNA] 		CTD PMID:21858171 NCBI chr 2:47,856,345...47,863,670
Ensembl chr 2:47,856,345...47,863,491 		JBrowse link
G Fut8 fucosyltransferase 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of FUT8 mRNA CTD PMID:21858171 NCBI chr 6:101,682,354...101,909,784
Ensembl chr 6:101,683,007...101,909,775 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase decreases expression ISO Piroxicam results in decreased expression of FYN mRNA CTD PMID:21858171 NCBI chr20:44,322,635...44,514,498
Ensembl chr20:44,322,361...44,515,479 		JBrowse link
G Gar1 GAR1 ribonucleoprotein decreases expression ISO Piroxicam results in decreased expression of GAR1 mRNA CTD PMID:21858171 NCBI chr 2:221,049,471...221,056,749
Ensembl chr 2:221,049,473...221,056,749 		JBrowse link
G Gbp1 guanylate binding protein 1 decreases expression ISO Piroxicam results in decreased expression of GBP1 mRNA CTD PMID:19192274 NCBI chr 2:234,071,366...234,106,012
Ensembl chr 2:234,190,708...234,206,802
Ensembl chr 2:234,190,708...234,206,802 		JBrowse link
G Gcsh glycine cleavage system protein H decreases expression ISO Piroxicam results in decreased expression of GCSH mRNA CTD PMID:21858171 NCBI chr19:61,944,850...61,955,607
Ensembl chr19:61,944,850...61,955,607 		JBrowse link
G Gdf15 growth differentiation factor 15 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GDF15 mRNA] CTD PMID:21858171 NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,838,436...18,842,022 		JBrowse link
G Gins1 GINS complex subunit 1 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of GINS1 mRNA] CTD PMID:21858171 NCBI chr 3:160,184,920...160,206,334
Ensembl chr 3:160,180,151...160,206,332 		JBrowse link
G Gins2 GINS complex subunit 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of GINS2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of GINS2 mRNA] 		CTD PMID:21858171 NCBI chr19:65,535,492...65,548,270
Ensembl chr19:65,535,492...65,548,052 		JBrowse link
G Gins3 GINS complex subunit 3 increases expression ISO Piroxicam results in increased expression of GINS3 mRNA CTD PMID:21858171 NCBI chr19:9,426,140...9,435,192
Ensembl chr19:9,399,759...9,434,679 		JBrowse link
G Gla galactosidase, alpha decreases expression ISO Piroxicam results in decreased expression of GLA mRNA CTD PMID:21858171 NCBI chr  X:102,062,497...102,073,915
Ensembl chr  X:102,056,718...102,073,915 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 decreases expression ISO Piroxicam results in decreased expression of GLIPR1 mRNA CTD PMID:21858171 NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:49,373,581...49,384,640 		JBrowse link
G Gm2a ganglioside GM2 activator multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GM2A mRNA CTD PMID:21858171 NCBI chr10:39,719,919...39,732,452
Ensembl chr10:39,719,938...39,732,451 		JBrowse link
G Gmnn geminin, DNA replication inhibitor decreases expression ISO Piroxicam results in decreased expression of GMNN mRNA CTD PMID:21858171 NCBI chr17:40,729,760...40,738,077
Ensembl chr17:40,729,824...40,738,068 		JBrowse link
G Gng11 G protein subunit gamma 11 decreases expression ISO Piroxicam results in decreased expression of GNG11 mRNA CTD PMID:21858171 NCBI chr 4:32,977,681...32,983,121
Ensembl chr 4:32,977,664...32,984,438 		JBrowse link
G Gpaa1 glycosylphosphatidylinositol anchor attachment 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GPAA1 mRNA CTD PMID:21858171 NCBI chr 7:109,932,556...109,936,139
Ensembl chr 7:109,932,544...109,936,138 		JBrowse link
G Gpc1 glypican 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GPC1 mRNA CTD PMID:21858171 NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:100,843,645...100,879,933 		JBrowse link
G Grn granulin precursor multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of GRN mRNA] CTD PMID:21858171 NCBI chr10:87,887,834...87,893,938
Ensembl chr10:87,886,122...87,893,936 		JBrowse link
G Gsdme gasdermin E decreases expression ISO Piroxicam results in decreased expression of GSDME mRNA CTD PMID:19192274 NCBI chr 4:80,590,344...80,651,943
Ensembl chr 4:80,588,614...80,641,525 		JBrowse link
G Gstt1 glutathione S-transferase theta 1 increases expression EXP Piroxicam results in increased expression of GSTT1 protein CTD PMID:9729437 NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,083...12,873,019 		JBrowse link
G Gtf2ird1 GTF2I repeat domain containing 1 decreases expression ISO Piroxicam results in decreased expression of GTF2IRD1 mRNA CTD PMID:21858171 NCBI chr12:27,890,594...27,997,506
Ensembl chr12:27,890,675...27,997,494 		JBrowse link
G Gulp1 GULP PTB domain containing engulfment adaptor 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of GULP1 mRNA CTD PMID:21858171 NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:54,114,731...54,397,452 		JBrowse link
G H2ax H2A.X variant histone decreases expression ISO Piroxicam results in decreased expression of H2AX mRNA CTD PMID:21858171 NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079 		JBrowse link
G Hat1 histone acetyltransferase 1 decreases expression ISO Piroxicam results in decreased expression of HAT1 mRNA CTD PMID:21858171 NCBI chr 3:76,624,442...76,672,701
Ensembl chr 3:76,624,869...76,672,696 		JBrowse link
G Hexim1 HEXIM P-TEFb complex subunit 1 decreases expression ISO Piroxicam results in decreased expression of HEXIM1 mRNA CTD PMID:21858171 NCBI chr10:88,562,889...88,565,001
Ensembl chr10:88,560,519...88,580,000 		JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated decreases expression ISO Piroxicam results in decreased expression of HILPDA mRNA CTD PMID:19192274 NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:58,836,463...58,839,423 		JBrowse link
G Hmga2 high mobility group AT-hook 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HMGA2 mRNA CTD PMID:21858171 NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:57,765,675...57,880,341 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase decreases expression ISO Piroxicam results in decreased expression of HMGCR mRNA CTD PMID:21858171 NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:29,720,553...29,754,533 		JBrowse link
G Hmgn3 high mobility group nucleosomal binding domain 3 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of HMGN3 mRNA] CTD PMID:21858171 NCBI chr 8:92,902,555...92,939,980 JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HMMR mRNA CTD PMID:21858171 NCBI chr10:25,635,249...25,665,389
Ensembl chr10:25,635,915...25,665,390 		JBrowse link
G Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of HNRNPA3 mRNA] CTD PMID:21858171 NCBI chr 3:80,984,470...80,999,413
Ensembl chr 3:80,985,969...80,996,043 		JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of HNRNPD mRNA] CTD PMID:21858171 NCBI chr14:9,918,630...9,938,072
Ensembl chr14:9,919,739...9,938,066 		JBrowse link
G Hnrnpl heterogeneous nuclear ribonucleoprotein L multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HNRNPL mRNA CTD PMID:21858171 NCBI chr 1:93,226,373...93,239,084
Ensembl chr 1:93,235,729...93,239,061 		JBrowse link
G Hoxa9 homeobox A9 decreases expression ISO Piroxicam results in decreased expression of HOXA9 mRNA CTD PMID:21858171 NCBI chr 4:82,653,847...82,659,958
Ensembl chr 4:82,653,825...82,662,093 		JBrowse link
G Hs2st1 heparan sulfate 2-O-sulfotransferase 1 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of HS2ST1 mRNA] CTD PMID:21858171 NCBI chr 2:236,168,391...236,302,186
Ensembl chr 2:236,168,392...236,302,133 		JBrowse link
G Hsbp1 heat shock factor binding protein 1 decreases expression ISO Piroxicam results in decreased expression of HSBP1 mRNA CTD PMID:21858171 NCBI chr19:64,309,703...64,314,035
Ensembl chr19:64,309,703...64,314,035 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 decreases expression ISO Piroxicam results in decreased expression of HSD11B1 mRNA CTD PMID:19192274 NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432 		JBrowse link
G Hsd17b11 hydroxysteroid (17-beta) dehydrogenase 11 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HSD17B11 mRNA CTD PMID:21858171 NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,997,906...6,047,811 		JBrowse link
G Hspa14 heat shock protein family A (Hsp70) member 14 increases expression
multiple interactions 		ISO Piroxicam results in increased expression of HSPA14 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of HSPA14 mRNA] 		CTD PMID:21858171 NCBI chr17:79,638,106...79,658,888
Ensembl chr17:79,638,058...79,658,885 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of HSPA1A mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of HSPA1A mRNA] 		CTD PMID:21858171 NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of HSPA1B mRNA] CTD PMID:21858171 NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,855,780...3,877,979 		JBrowse link
G Hspa4l heat shock protein family A (Hsp70) member 4 like multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HSPA4L mRNA CTD PMID:21858171 NCBI chr 2:125,668,346...125,726,404
Ensembl chr 2:125,668,236...125,720,986 		JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 decreases expression ISO Piroxicam results in decreased expression of HSPA9 mRNA CTD PMID:21858171 NCBI chr18:26,810,004...26,832,958
Ensembl chr18:26,804,774...26,828,398 		JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of HSPE1 mRNA] CTD PMID:21858171 NCBI chr 9:64,084,327...64,087,415
Ensembl chr 9:64,085,068...64,087,502 		JBrowse link
G Hsph1 heat shock protein family H (Hsp110) member 1 decreases expression ISO Piroxicam results in decreased expression of HSPH1 mRNA CTD PMID:21858171 NCBI chr12:10,427,368...10,446,602
Ensembl chr12:10,427,297...10,446,891 		JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha decreases expression ISO Piroxicam results in decreased expression of IDH3A mRNA CTD PMID:21858171 NCBI chr 8:63,867,882...63,887,223
Ensembl chr 8:63,867,820...63,887,223 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Piroxicam results in decreased expression of IDI1 mRNA CTD PMID:21858171 NCBI chr17:66,539,761...66,547,524
Ensembl chr17:66,539,763...66,547,524 		JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 decreases expression ISO Piroxicam results in decreased expression of IFI27 mRNA CTD PMID:19192274 NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:128,355,079...128,361,781 		JBrowse link
G Ifi44l interferon-induced protein 44-like decreases expression ISO Piroxicam results in decreased expression of IFI44L mRNA CTD PMID:19192274 NCBI chr 2:243,328,629...243,366,404
Ensembl chr 2:243,328,723...243,366,404 		JBrowse link
G Il1rn interleukin 1 receptor antagonist decreases expression ISO Piroxicam results in decreased expression of IL1RN mRNA CTD PMID:19192274 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732 		JBrowse link
G Il23a interleukin 23 subunit alpha decreases expression ISO Piroxicam results in decreased expression of IL23A mRNA CTD PMID:19192274 NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434 		JBrowse link
G Il6 interleukin 6 decreases expression ISO Piroxicam results in decreased expression of IL6 mRNA; Piroxicam results in decreased expression of IL6 protein CTD PMID:19192274 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610 		JBrowse link
G Ilf3 interleukin enhancer binding factor 3 decreases expression ISO Piroxicam results in decreased expression of ILF3 mRNA CTD PMID:21858171 NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:28,198,543...28,236,612 		JBrowse link
G Insig1 insulin induced gene 1 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of INSIG1 mRNA] CTD PMID:21858171 NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:8,049,556...8,057,778 		JBrowse link
G Ipo7 importin 7 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of IPO7 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of IPO7 mRNA] 		CTD PMID:21858171 NCBI chr 1:173,497,472...173,537,707
Ensembl chr 1:173,497,503...173,536,778 		JBrowse link
G Iqcb1 IQ motif containing B1 decreases expression ISO Piroxicam results in decreased expression of IQCB1 mRNA CTD PMID:21858171 NCBI chr11:77,410,986...77,465,540
Ensembl chr11:77,410,314...77,465,478 		JBrowse link
G Irs2 insulin receptor substrate 2 decreases expression ISO Piroxicam results in decreased expression of IRS2 mRNA CTD PMID:21858171 NCBI chr16:85,190,310...85,214,543
Ensembl chr16:85,190,111...85,214,543 		JBrowse link
G Isg15 ISG15 ubiquitin-like modifier decreases expression ISO Piroxicam results in decreased expression of ISG15 mRNA CTD PMID:19192274 NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:172,066,369...172,067,656 		JBrowse link
G Isg20 interferon stimulated exonuclease gene 20 decreases expression ISO Piroxicam results in decreased expression of ISG20 mRNA CTD PMID:19192274 NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:142,236,137...142,246,401 		JBrowse link
G Itgb3bp integrin subunit beta 3 binding protein decreases expression ISO Piroxicam results in decreased expression of ITGB3BP mRNA CTD PMID:21858171 NCBI chr 5:119,575,657...119,640,974
Ensembl chr 5:119,575,248...119,640,997 		JBrowse link
G Jag2 jagged canonical Notch ligand 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of JAG2 mRNA CTD PMID:21858171 NCBI chr 6:137,804,133...137,826,738
Ensembl chr 6:137,804,133...137,826,738 		JBrowse link
G Jmjd6 jumonji domain containing 6, arginine demethylase and lysine hydroxylase increases expression ISO Piroxicam results in increased expression of JMJD6 mRNA CTD PMID:21858171 NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,539,894...102,545,986 		JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Piroxicam results in decreased expression of JUND mRNA CTD PMID:21858171 NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,764,985...18,782,148 		JBrowse link
G Kcnma1 potassium calcium-activated channel subfamily M alpha 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KCNMA1 mRNA CTD PMID:21858171 NCBI chr15:351,065...1,057,117
Ensembl chr15:351,659...1,057,117 		JBrowse link
G Kdelr2 KDEL endoplasmic reticulum protein retention receptor 2 decreases expression ISO Piroxicam results in decreased expression of KDELR2 mRNA CTD PMID:21858171 NCBI chr12:16,252,424...16,270,737
Ensembl chr12:16,252,424...16,270,719 		JBrowse link
G Kif11 kinesin family member 11 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of KIF11 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of KIF11 mRNA] 		CTD PMID:21858171 NCBI chr 1:244,494,916...244,589,250
Ensembl chr 1:244,494,875...244,589,250 		JBrowse link
G Kif14 kinesin family member 14 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of KIF14 mRNA] CTD PMID:21858171 NCBI chr13:50,478,646...50,542,256
Ensembl chr13:50,478,721...50,542,248 		JBrowse link
G Kif18a kinesin family member 18A decreases expression ISO Piroxicam results in decreased expression of KIF18A mRNA CTD PMID:21858171 NCBI chr 3:116,219,007...116,279,378
Ensembl chr 3:116,219,007...116,279,227 		JBrowse link
G Kif20a kinesin family member 20A multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of KIF20A mRNA] CTD PMID:21858171 NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,504,072...26,512,909 		JBrowse link
G Kif23 kinesin family member 23 decreases expression ISO Piroxicam results in decreased expression of KIF23 mRNA CTD PMID:21858171 NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:71,293,482...71,320,856 		JBrowse link
G Kif2c kinesin family member 2C increases expression ISO Piroxicam results in increased expression of KIF2C mRNA CTD PMID:21858171 NCBI chr 5:135,873,925...135,899,267
Ensembl chr 5:135,873,925...135,899,212 		JBrowse link
G Kif4a kinesin family member 4A multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KIF4A mRNA CTD PMID:21858171 NCBI chr  X:69,761,803...69,864,335
Ensembl chr  X:69,761,883...69,864,335 		JBrowse link
G Klf4 KLF transcription factor 4 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of KLF4 mRNA CTD PMID:21858171 NCBI chr 5:75,074,107...75,079,182
Ensembl chr 5:75,074,236...75,078,592 		JBrowse link
G Klhl21 kelch-like family member 21 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of KLHL21 mRNA CTD PMID:21858171 NCBI chr 5:167,797,621...167,806,276
Ensembl chr 5:167,797,591...167,806,276 		JBrowse link
G Kpna1 karyopherin subunit alpha 1 decreases expression ISO Piroxicam results in decreased expression of KPNA1 mRNA CTD PMID:21858171 NCBI chr11:78,221,165...78,279,778
Ensembl chr11:78,222,884...78,267,067 		JBrowse link
G Kpna2 karyopherin subunit alpha 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of KPNA2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of KPNA2 mRNA] 		CTD PMID:21858171 NCBI chr10:92,433,678...92,445,841
Ensembl chr10:92,433,679...92,445,937 		JBrowse link
G Kpnb1 karyopherin subunit beta 1 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of KPNB1 mRNA] CTD PMID:21858171 NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,642,082...82,670,856 		JBrowse link
G Krr1 KRR1, small subunit processome component homolog increases expression ISO Piroxicam results in increased expression of KRR1 mRNA CTD PMID:21858171 NCBI chr 7:49,361,794...49,374,222
Ensembl chr 7:49,361,901...49,374,216 		JBrowse link
G Lamb3 laminin subunit beta 3 decreases expression ISO Piroxicam results in decreased expression of LAMB3 mRNA CTD PMID:19192274 NCBI chr13:107,362,514...107,404,081
Ensembl chr13:107,322,526...107,404,081 		JBrowse link
G Lamc1 laminin subunit gamma 1 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of LAMC1 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of LAMC1 mRNA] 		CTD PMID:21858171 NCBI chr13:67,924,872...68,051,986
Ensembl chr13:67,924,872...68,051,986 		JBrowse link
G Lbr lamin B receptor multiple interactions
increases expression 		ISO Cisplatin affects the reaction [Piroxicam results in increased expression of LBR mRNA] CTD PMID:21858171 NCBI chr13:96,071,058...96,095,709
Ensembl chr13:96,071,081...96,095,709 		JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of LDLR mRNA] CTD PMID:21858171 NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:28,546,146...28,570,675 		JBrowse link
G Lgals3bp galectin 3 binding protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of LGALS3BP mRNA CTD PMID:21858171 NCBI chr10:104,118,510...104,127,848
Ensembl chr10:104,118,510...104,127,848 		JBrowse link
G Lhfpl2 LHFPL tetraspan subfamily member 2 increases expression ISO Piroxicam results in increased expression of LHFPL2 mRNA CTD PMID:21858171 NCBI chr 2:27,016,404...27,169,830
Ensembl chr 2:27,016,700...27,162,859 		JBrowse link
G Lrba LPS responsive beige-like anchor protein multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of LRBA mRNA CTD PMID:21858171 NCBI chr 2:173,919,330...174,500,536
Ensembl chr 2:173,921,747...174,500,527 		JBrowse link
G Lxn latexin increases expression ISO Piroxicam results in increased expression of LXN mRNA CTD PMID:19192274 NCBI chr 2:154,037,604...154,043,473
Ensembl chr 2:154,037,292...154,043,488 		JBrowse link
G Ly6e lymphocyte antigen 6 family member E decreases expression ISO Piroxicam results in decreased expression of LY6E mRNA CTD PMID:19192274 NCBI chr 7:108,815,970...108,820,444
Ensembl chr 7:108,816,887...108,820,443 		JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 increases expression ISO Piroxicam results in increased expression of MAD2L1 mRNA CTD PMID:21858171 NCBI chr 4:97,236,419...97,247,603
Ensembl chr 4:97,236,503...97,243,222 		JBrowse link
G Magoh mago homolog, exon junction complex subunit increases expression ISO Piroxicam results in increased expression of MAGOH mRNA CTD PMID:21858171 NCBI chr 5:127,868,044...127,875,423
Ensembl chr 5:127,868,055...127,875,384 		JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MANF mRNA] CTD PMID:21858171 NCBI chr 8:116,427,053...116,430,259
Ensembl chr 8:116,427,048...116,429,910 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate decreases expression ISO Piroxicam results in decreased expression of MARCKS mRNA CTD PMID:19192274 NCBI chr20:42,240,185...42,245,882
Ensembl chr20:42,240,185...42,245,882 		JBrowse link
G Mars1 methionyl-tRNA synthetase 1 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MARS1 mRNA] CTD PMID:21858171 NCBI chr 7:65,006,456...65,023,880
Ensembl chr 7:64,998,544...65,023,753 		JBrowse link
G Mcam melanoma cell adhesion molecule decreases expression ISO Piroxicam results in decreased expression of MCAM mRNA CTD PMID:21858171 NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406 		JBrowse link
G Mcm3 minichromosome maintenance complex component 3 decreases expression ISO Piroxicam results in decreased expression of MCM3 mRNA CTD PMID:21858171 NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:30,715,602...30,733,746 		JBrowse link
G Mcm4 minichromosome maintenance complex component 4 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of MCM4 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MCM4 mRNA] 		CTD PMID:21858171 NCBI chr11:98,762,599...98,776,300
Ensembl chr11:98,762,634...98,776,536 		JBrowse link
G Mcm5 minichromosome maintenance complex component 5 increases expression ISO Piroxicam results in increased expression of MCM5 mRNA CTD PMID:21858171 NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,488,813...13,517,758 		JBrowse link
G Mcm6 minichromosome maintenance complex component 6 decreases expression ISO Piroxicam results in decreased expression of MCM6 mRNA CTD PMID:21858171 NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467 		JBrowse link
G Mdk midkine increases expression ISO Piroxicam results in increased expression of MDK mRNA CTD PMID:21858171 NCBI chr 3:98,356,789...98,358,960
Ensembl chr 3:98,356,789...98,358,743 		JBrowse link
G Med21 mediator complex subunit 21 decreases expression ISO Piroxicam results in decreased expression of MED21 mRNA CTD PMID:21858171 NCBI chr 4:181,291,191...181,314,504
Ensembl chr 4:181,291,271...181,298,234 		JBrowse link
G Med27 mediator complex subunit 27 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of MED27 mRNA CTD PMID:21858171 NCBI chr 3:33,027,240...33,201,240
Ensembl chr 3:33,027,525...33,201,240 		JBrowse link
G Meis2 Meis homeobox 2 decreases expression ISO Piroxicam results in decreased expression of MEIS2 mRNA CTD PMID:21858171 NCBI chr 3:123,197,066...123,399,002
Ensembl chr 3:123,197,066...123,397,751 		JBrowse link
G Mest mesoderm specific transcript decreases expression ISO Piroxicam results in decreased expression of MEST mRNA CTD PMID:21858171 NCBI chr 4:60,321,814...60,332,288
Ensembl chr 4:60,316,102...60,333,509 		JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase decreases expression ISO Piroxicam results in decreased expression of MET mRNA CTD PMID:19192274 NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:46,756,506...46,870,821 		JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of MGAT2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MGAT2 mRNA] 		CTD PMID:21858171 NCBI chr 6:93,392,416...93,394,905
Ensembl chr 6:93,390,555...93,395,176 		JBrowse link
G Mink1 misshapen-like kinase 1 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of MINK1 mRNA] CTD PMID:21858171 NCBI chr10:55,776,879...55,829,406
Ensembl chr10:55,776,993...55,829,406 		JBrowse link
G Mis18a MIS18 kinetochore protein A multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of MIS18A mRNA] CTD PMID:21858171 NCBI chr11:43,454,129...43,467,157
Ensembl chr11:43,454,161...43,476,264 		JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Piroxicam results in decreased expression of MKI67 mRNA CTD PMID:21858171 NCBI chr 1:199,926,150...199,952,847
Ensembl chr 1:199,926,150...199,952,593 		JBrowse link
G Mllt11 MLLT11, transcription factor 7 cofactor decreases expression ISO Piroxicam results in decreased expression of MLLT11 mRNA CTD PMID:21858171 NCBI chr 2:185,484,791...185,493,961
Ensembl chr 2:185,484,793...185,493,961 		JBrowse link
G Mmp10 matrix metallopeptidase 10 decreases expression ISO Piroxicam results in decreased expression of MMP10 mRNA CTD PMID:19192274 NCBI chr 8:12,974,707...12,982,613
Ensembl chr 8:12,974,707...12,982,613 		JBrowse link
G Mmp2 matrix metallopeptidase 2 decreases activity ISO Piroxicam results in decreased activity of MMP2 protein CTD PMID:15990687 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856 		JBrowse link
G Mob1a MOB kinase activator 1A decreases expression ISO Piroxicam results in decreased expression of MOB1A mRNA CTD PMID:21858171 NCBI chr 4:117,389,278...117,406,255
Ensembl chr 4:117,389,186...117,406,250 		JBrowse link
G Mpo myeloperoxidase decreases activity
increases activity
multiple interactions
increases expression 		EXP Piroxicam results in decreased activity of MPO
Piroxicam results in increased activity of MPO protein
pantoprazole inhibits the reaction [Piroxicam results in increased expression of MPO protein] 		CTD PMID:11996850 PMID:15309881 PMID:16080005 NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056 		JBrowse link
G Mr1 major histocompatibility complex, class I-related affects expression ISO Piroxicam affects the expression of MR1 mRNA CTD PMID:25811541 NCBI chr13:69,850,420...69,868,302
Ensembl chr13:69,850,420...69,868,502 		JBrowse link
G Mrpl13 mitochondrial ribosomal protein L13 decreases expression ISO Piroxicam results in decreased expression of MRPL13 mRNA CTD PMID:21858171 NCBI chr 7:88,841,265...88,862,821
Ensembl chr 7:88,841,266...88,862,848 		JBrowse link
G Mrpl16 mitochondrial ribosomal protein L16 decreases expression ISO Piroxicam results in decreased expression of MRPL16 mRNA CTD PMID:21858171 NCBI chr 1:218,058,439...218,063,251
Ensembl chr 1:218,058,433...218,064,898 		JBrowse link
G Msh2 mutS homolog 2 decreases expression ISO Piroxicam results in decreased expression of MSH2 mRNA CTD PMID:21858171 NCBI chr 6:12,567,368...12,626,534
Ensembl chr 6:12,567,368...12,626,503 		JBrowse link
G Msh6 mutS homolog 6 decreases expression ISO Piroxicam results in decreased expression of MSH6 mRNA CTD PMID:21858171 NCBI chr 6:12,316,190...12,333,505
Ensembl chr 6:12,316,198...12,333,844 		JBrowse link
G Msmo1 methylsterol monooxygenase 1 decreases expression ISO Piroxicam results in decreased expression of MSMO1 mRNA CTD PMID:21858171 NCBI chr16:29,747,113...29,764,360
Ensembl chr16:29,747,137...29,764,445 		JBrowse link
G Mt2 metallothionein 2 decreases expression ISO Piroxicam results in decreased expression of MT2A mRNA CTD PMID:21858171 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709 		JBrowse link
G Mx1 MX dynamin like GTPase 1 decreases expression ISO Piroxicam results in decreased expression of MX1 mRNA CTD PMID:19192274 NCBI chr11:50,269,056...50,294,699
Ensembl chr11:50,269,057...50,292,904 		JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions EXP Piroxicam inhibits the reaction [Azoxymethane results in increased expression of MYC mRNA]; Piroxicam inhibits the reaction [Azoxymethane results in increased expression of MYC protein] CTD PMID:12189186 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028 		JBrowse link
G Mycbp Myc binding protein multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of MYCBP mRNA] CTD PMID:21858171 NCBI chr 5:141,420,727...141,427,938
Ensembl chr 5:141,420,707...141,430,681 		JBrowse link
G Naa15 N(alpha)-acetyltransferase 15, NatA auxiliary subunit increases expression ISO Piroxicam results in increased expression of NAA15 mRNA CTD PMID:21858171 NCBI chr 2:137,608,883...137,671,618
Ensembl chr 2:137,608,797...137,671,619 		JBrowse link
G Nab1 Ngfi-A binding protein 1 decreases expression ISO Piroxicam results in decreased expression of NAB1 mRNA CTD PMID:21858171 NCBI chr 9:56,545,547...56,585,045
Ensembl chr 9:56,545,729...56,614,210 		JBrowse link
G Nap1l1 nucleosome assembly protein 1-like 1 increases expression ISO Piroxicam results in increased expression of NAP1L1 mRNA CTD PMID:21858171 NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:48,819,477...48,844,104 		JBrowse link
G Nasp nuclear autoantigenic sperm protein decreases expression ISO Piroxicam results in decreased expression of NASP mRNA CTD PMID:21858171 NCBI chr 5:135,294,599...135,319,992
Ensembl chr 5:135,294,032...135,319,591 		JBrowse link
G Nbr1 NBR1, autophagy cargo receptor multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NBR1 mRNA] CTD PMID:21858171 NCBI chr10:86,477,775...86,506,418
Ensembl chr10:86,977,885...87,007,012 		JBrowse link
G Ncapd3 non-SMC condensin II complex, subunit D3 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NCAPD3 mRNA] CTD PMID:21858171 NCBI chr 8:33,696,214...33,765,520
Ensembl chr 8:33,696,270...33,765,518 		JBrowse link
G Ncapg non-SMC condensin I complex, subunit G decreases expression ISO Piroxicam results in decreased expression of NCAPG mRNA CTD PMID:21858171 NCBI chr14:69,616,473...69,645,445
Ensembl chr14:69,616,473...69,645,445 		JBrowse link
G Ncaph non-SMC condensin I complex, subunit H multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NCAPH mRNA] CTD PMID:21858171 NCBI chr 3:134,825,271...134,852,502
Ensembl chr 3:134,825,271...134,852,502 		JBrowse link
G Nck1 NCK adaptor protein 1 decreases expression ISO Piroxicam results in decreased expression of NCK1 mRNA CTD PMID:21858171 NCBI chr 8:109,897,723...109,958,247
Ensembl chr 8:109,897,724...109,958,247 		JBrowse link
G Ndc80 NDC80 kinetochore complex component multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of NDC80 mRNA] CTD PMID:21858171 NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:118,853,806...118,887,568 		JBrowse link
G Ndufa4l2 NDUFA4, mitochondrial complex associated like 2 decreases expression ISO Piroxicam results in decreased expression of NDUFA4L2 mRNA CTD PMID:19192274 NCBI chr 7:65,242,169...65,244,296
Ensembl chr 7:65,242,135...65,244,277 		JBrowse link
G Ndufa5 NADH:ubiquinone oxidoreductase subunit A5 decreases expression ISO Piroxicam results in decreased expression of NDUFA5 mRNA CTD PMID:21858171 NCBI chr 4:53,962,877...53,971,235
Ensembl chr 4:53,962,877...53,971,235 		JBrowse link
G Nek9 NIMA-related kinase 9 increases expression ISO Piroxicam results in increased expression of NEK9 mRNA CTD PMID:21858171 NCBI chr 6:110,675,107...110,715,586
Ensembl chr 6:110,675,107...110,715,586 		JBrowse link
G Net1 neuroepithelial cell transforming 1 decreases expression ISO Piroxicam results in decreased expression of NET1 mRNA CTD PMID:21858171 NCBI chr17:71,251,145...71,280,345
Ensembl chr17:71,251,149...71,289,270 		JBrowse link
G Nfatc3 nuclear factor of activated T-cells 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NFATC3 mRNA CTD PMID:21858171 NCBI chr19:50,870,464...50,944,992
Ensembl chr19:50,870,489...50,944,992 		JBrowse link
G Nfe2l1 NFE2 like bZIP transcription factor 1 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of NFE2L1 mRNA] CTD PMID:21858171 NCBI chr10:82,296,824...82,309,472
Ensembl chr10:82,292,508...82,309,375 		JBrowse link
G Niban1 niban apoptosis regulator 1 decreases expression ISO Piroxicam results in decreased expression of NIBAN1 mRNA CTD PMID:21858171 NCBI chr13:63,674,240...63,827,748
Ensembl chr13:66,224,021...66,377,724 		JBrowse link
G Nid2 nidogen 2 increases expression ISO Piroxicam results in increased expression of NID2 mRNA CTD PMID:19192274 NCBI chr15:4,507,224...4,562,949
Ensembl chr15:4,506,756...4,562,949 		JBrowse link
G Nisch nischarin multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of NISCH mRNA CTD PMID:21858171 NCBI chr16:6,370,809...6,407,104
Ensembl chr16:6,370,809...6,407,387 		JBrowse link
G Nkx3-1 NK3 homeobox 1 multiple interactions ISO Piroxicam inhibits the reaction [mibolerone results in increased expression of NKX3-1 mRNA] CTD PMID:10537180 NCBI chr15:50,883,661...50,886,253
Ensembl chr15:50,883,597...50,886,251 		JBrowse link
G Nle1 notchless homolog 1 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of NLE1 mRNA] CTD PMID:21858171 NCBI chr10:68,331,609...68,342,562
Ensembl chr10:68,331,609...68,340,386 		JBrowse link
G Nme7 NME/NM23 family member 7 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NME7 mRNA CTD PMID:21858171 NCBI chr13:79,190,462...79,319,890
Ensembl chr13:79,190,334...79,319,890 		JBrowse link
G Nmt2 N-myristoyltransferase 2 decreases expression ISO Piroxicam results in decreased expression of NMT2 mRNA CTD PMID:21858171 NCBI chr17:79,826,999...79,874,088
Ensembl chr17:79,826,999...79,870,259 		JBrowse link
G Nol8 nucleolar protein 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of NOL8 mRNA CTD PMID:21858171 NCBI chr17:15,196,881...15,220,265
Ensembl chr17:15,196,881...15,220,202 		JBrowse link
G Nolc1 nucleolar and coiled-body phosphoprotein 1 increases expression ISO Piroxicam results in increased expression of NOLC1 mRNA CTD PMID:21858171 NCBI chr 1:254,870,195...254,881,070
Ensembl chr 1:254,870,319...254,881,069 		JBrowse link
G Npdc1 neural proliferation, differentiation and control, 1 decreases expression ISO Piroxicam results in decreased expression of NPDC1 mRNA CTD PMID:21858171 NCBI chr 3:28,618,601...28,624,591 JBrowse link
G Nr4a3 nuclear receptor subfamily 4, group A, member 3 decreases expression ISO Piroxicam results in decreased expression of NR4A3 mRNA CTD PMID:19192274 NCBI chr 5:67,157,141...67,198,287
Ensembl chr 5:67,157,375...67,198,285 		JBrowse link
G Nrip1 nuclear receptor interacting protein 1 decreases expression ISO Piroxicam results in decreased expression of NRIP1 mRNA CTD PMID:21858171 NCBI chr11:28,382,835...28,466,483
Ensembl chr11:28,378,878...28,467,353 		JBrowse link
G Nrp1 neuropilin 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of NRP1 mRNA CTD PMID:21858171 NCBI chr19:73,256,557...73,411,705
Ensembl chr19:73,256,557...73,411,702 		JBrowse link
G Nsl1 NSL1 component of MIS12 kinetochore complex decreases expression ISO Piroxicam results in decreased expression of NSL1 mRNA CTD PMID:21858171 NCBI chr13:105,176,163...105,205,179
Ensembl chr13:105,180,183...105,196,117 		JBrowse link
G Nudt21 nudix hydrolase 21 decreases expression ISO Piroxicam results in decreased expression of NUDT21 mRNA CTD PMID:21858171 NCBI chr19:10,980,797...10,996,903
Ensembl chr19:10,980,158...10,999,754 		JBrowse link
G Nup160 nucleoporin 160 decreases expression ISO Piroxicam results in decreased expression of NUP160 mRNA CTD PMID:21858171 NCBI chr 3:76,665,786...76,729,296
Ensembl chr 3:97,121,628...97,180,720 		JBrowse link
G Nup50 nucleoporin 50 decreases expression ISO Piroxicam results in decreased expression of NUP50 mRNA CTD PMID:21858171 NCBI chr 7:117,927,882...117,945,155
Ensembl chr 7:117,925,716...117,946,959 		JBrowse link
G Nup85 nucleoporin 85 decreases expression ISO Piroxicam results in decreased expression of NUP85 mRNA CTD PMID:21858171 NCBI chr10:101,305,241...101,323,980
Ensembl chr10:101,305,390...101,324,641 		JBrowse link
G Nup88 nucleoporin 88 decreases expression ISO Piroxicam results in decreased expression of NUP88 mRNA CTD PMID:21858171 NCBI chr10:56,166,486...56,190,829
Ensembl chr10:56,166,486...56,191,383 		JBrowse link
G Nxt2 nuclear transport factor 2-like export factor 2 increases expression ISO Piroxicam results in increased expression of NXT2 mRNA CTD PMID:21858171 NCBI chr  X:110,652,434...110,659,738
Ensembl chr  X:110,652,434...110,659,737 		JBrowse link
G Ogt O-linked N-acetylglucosamine (GlcNAc) transferase multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of OGT mRNA] CTD PMID:21858171 NCBI chr  X:70,811,317...70,856,123
Ensembl chr  X:70,811,319...70,856,123 		JBrowse link
G Olfml2b olfactomedin-like 2B increases expression ISO Piroxicam results in increased expression of OLFML2B mRNA CTD PMID:19192274 NCBI chr13:85,402,151...85,439,342
Ensembl chr13:85,402,169...85,439,342 		JBrowse link
G Opa1 OPA1, mitochondrial dynamin like GTPase decreases expression ISO Piroxicam results in decreased expression of OPA1 mRNA CTD PMID:21858171 NCBI chr11:84,612,943...84,690,025
Ensembl chr11:84,615,340...84,689,955 		JBrowse link
G Optn optineurin decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of OPTN mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of OPTN mRNA] 		CTD PMID:21858171 NCBI chr17:78,118,847...78,169,543
Ensembl chr17:78,118,866...78,169,543 		JBrowse link
G Orc6 origin recognition complex, subunit 6 decreases expression ISO Piroxicam results in decreased expression of ORC6 mRNA CTD PMID:21858171 NCBI chr19:37,931,085...37,938,856
Ensembl chr19:37,931,090...37,938,856 		JBrowse link
G Pa2g4 proliferation-associated 2G4 increases expression ISO Piroxicam results in increased expression of PA2G4 mRNA CTD PMID:21858171 NCBI chr 7:1,569,326...1,576,794
Ensembl chr 7:1,569,327...1,576,802 		JBrowse link
G Pacsin2 protein kinase C and casein kinase substrate in neurons 2 increases expression ISO Piroxicam results in increased expression of PACSIN2 mRNA CTD PMID:21858171 NCBI chr 7:116,385,571...116,478,609
Ensembl chr 7:116,384,190...116,478,537 		JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of PAFAH1B1 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PAFAH1B1 mRNA] 		CTD PMID:21858171 NCBI chr10:60,031,441...60,090,259
Ensembl chr10:60,032,514...60,090,196 		JBrowse link
G Palld palladin, cytoskeletal associated protein decreases expression ISO Piroxicam results in decreased expression of PALLD mRNA CTD PMID:21858171 NCBI chr16:33,238,943...33,632,236
Ensembl chr16:33,238,956...33,632,232 		JBrowse link
G Pank2 pantothenate kinase 2 increases expression ISO Piroxicam results in increased expression of PANK2 mRNA CTD PMID:21858171 NCBI chr 3:138,936,448...138,974,196
Ensembl chr 3:138,936,452...138,974,194 		JBrowse link
G Paxip1 PAX interacting protein 1 decreases expression ISO Piroxicam results in decreased expression of PAXIP1 mRNA CTD PMID:21858171 NCBI chr 4:8,258,930...8,310,490
Ensembl chr 4:8,258,952...8,310,488 		JBrowse link
G Pbk PDZ binding kinase decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of PBK mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of PBK mRNA] 		CTD PMID:21858171 NCBI chr15:44,198,506...44,209,572
Ensembl chr15:44,198,544...44,209,570 		JBrowse link
G Pbx1 PBX homeobox 1 increases expression ISO Piroxicam results in increased expression of PBX1 mRNA CTD PMID:21858171 NCBI chr13:82,811,664...83,121,447
Ensembl chr13:82,812,131...83,121,066 		JBrowse link
G Pcgf2 polycomb group ring finger 2 increases expression ISO Piroxicam results in increased expression of PCGF2 mRNA CTD PMID:21858171 NCBI chr10:83,178,926...83,191,610
Ensembl chr10:83,179,916...83,183,999 		JBrowse link
G Pclaf PCNA clamp associated factor decreases expression ISO Piroxicam results in decreased expression of PCLAF mRNA CTD PMID:21858171 NCBI chr 8:75,311,028...75,328,108
Ensembl chr 8:75,315,707...75,328,106 		JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO Piroxicam results in decreased expression of PCNA mRNA CTD PMID:21858171 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901 		JBrowse link
G Pdss1 decaprenyl diphosphate synthase subunit 1 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PDSS1 mRNA] CTD PMID:21858171 NCBI chr17:89,964,768...90,006,819
Ensembl chr17:89,968,034...90,006,817 		JBrowse link
G Pgls 6-phosphogluconolactonase increases expression ISO Piroxicam results in increased expression of PGLS mRNA CTD PMID:21858171 NCBI chr16:18,300,317...18,305,803
Ensembl chr16:18,334,299...18,339,785 		JBrowse link
G Pgrmc2 progesterone receptor membrane component 2 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PGRMC2 mRNA] CTD PMID:21858171 NCBI chr 2:125,996,190...126,012,090
Ensembl chr 2:125,996,193...126,012,090 		JBrowse link
G Phb1 prohibitin 1 decreases expression ISO Piroxicam results in decreased expression of PHB1 mRNA CTD PMID:21858171 NCBI chr10:81,102,043...81,114,815
Ensembl chr10:81,102,028...81,116,233 		JBrowse link
G Phgdh phosphoglycerate dehydrogenase multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PHGDH mRNA] CTD PMID:21858171 NCBI chr 2:188,595,700...188,624,789
Ensembl chr 2:188,595,700...188,624,789 		JBrowse link
G Phip pleckstrin homology domain interacting protein increases expression ISO Piroxicam results in increased expression of PHIP mRNA CTD PMID:21858171 NCBI chr 8:92,656,890...92,771,098
Ensembl chr 8:92,656,890...92,771,021 		JBrowse link
G Phlda2 pleckstrin homology-like domain, family A, member 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of PHLDA2 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PHLDA2 mRNA] 		CTD PMID:21858171 NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:208,126,302...208,127,920 		JBrowse link
G Pigp phosphatidylinositol glycan anchor biosynthesis, class P decreases expression ISO Piroxicam results in decreased expression of PIGP mRNA CTD PMID:21858171 NCBI chr11:47,152,601...47,158,766
Ensembl chr11:47,148,465...47,160,082 		JBrowse link
G Pik3r4 phosphoinositide-3-kinase, regulatory subunit 4 decreases expression ISO Piroxicam results in decreased expression of PIK3R4 mRNA CTD PMID:21858171 NCBI chr 8:115,146,660...115,195,326
Ensembl chr 8:115,146,687...115,195,326 		JBrowse link
G Pilra paired immunoglobin-like type 2 receptor alpha decreases expression ISO Piroxicam results in decreased expression of PILRA mRNA CTD PMID:19192274 NCBI chr12:23,452,626...23,464,772 JBrowse link
G Pink1 PTEN induced kinase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PINK1 mRNA CTD PMID:21858171 NCBI chr 5:155,813,838...155,825,950
Ensembl chr 5:155,813,838...155,825,950 		JBrowse link
G Plat plasminogen activator, tissue type decreases expression ISO Piroxicam results in decreased expression of PLAT mRNA CTD PMID:21858171 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696 		JBrowse link
G Plaur plasminogen activator, urokinase receptor decreases expression ISO Piroxicam results in decreased expression of PLAUR mRNA CTD PMID:21858171 NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:89,178,453...89,198,130 		JBrowse link
G Plk4 polo-like kinase 4 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLK4 mRNA] CTD PMID:21858171 NCBI chr 2:125,730,480...125,748,894
Ensembl chr 2:125,730,460...125,748,892 		JBrowse link
G Plpp3 phospholipid phosphatase 3 decreases expression ISO Piroxicam results in decreased expression of PLPP3 mRNA CTD PMID:19192274 NCBI chr 5:125,156,000...125,231,119
Ensembl chr 5:125,155,945...125,235,667 		JBrowse link
G Pls1 plastin 1 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of PLS1 mRNA] CTD PMID:21858171 NCBI chr 8:105,196,312...105,306,252
Ensembl chr 8:105,197,455...105,292,447 		JBrowse link
G Plxnb2 plexin B2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PLXNB2 mRNA CTD PMID:21858171 NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:122,111,917...122,127,746 		JBrowse link
G Pnn pinin, desmosome associated protein multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PNN mRNA] CTD PMID:21858171 NCBI chr 6:82,493,032...82,501,345
Ensembl chr 6:82,492,978...82,501,933 		JBrowse link
G Pold3 DNA polymerase delta 3, accessory subunit decreases expression ISO Piroxicam results in decreased expression of POLD3 mRNA CTD PMID:21858171 NCBI chr 1:163,830,217...163,870,015
Ensembl chr 1:163,830,437...163,869,202 		JBrowse link
G Pole2 DNA polymerase epsilon 2, accessory subunit increases expression
multiple interactions 		ISO Piroxicam results in increased expression of POLE2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in increased expression of POLE2 mRNA] 		CTD PMID:21858171 NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:93,410,758...93,435,361 		JBrowse link
G Pole3 DNA polymerase epsilon 3, accessory subunit decreases expression ISO Piroxicam results in decreased expression of POLE3 mRNA CTD PMID:21858171 NCBI chr 5:80,989,508...80,992,742
Ensembl chr 5:80,989,511...80,992,742
Ensembl chr 7:80,989,511...80,992,742 		JBrowse link
G Polr3k RNA polymerase III subunit K decreases expression ISO Piroxicam results in decreased expression of POLR3K mRNA CTD PMID:21858171 NCBI chr 3:189,360,349...189,364,546
Ensembl chr 3:189,360,171...189,366,697 		JBrowse link
G Pop7 POP7 homolog, ribonuclease P/MRP subunit decreases expression ISO Piroxicam results in decreased expression of POP7 mRNA CTD PMID:21858171 NCBI chr12:24,826,161...24,827,202
Ensembl chr12:24,809,994...24,827,522 		JBrowse link
G Ppm1b protein phosphatase, Mg2+/Mn2+ dependent, 1B multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of PPM1B mRNA CTD PMID:21858171 NCBI chr 6:15,399,559...15,460,301
Ensembl chr 6:15,399,562...15,460,756 		JBrowse link
G Ppp1cb protein phosphatase 1 catalytic subunit beta decreases expression ISO Piroxicam results in decreased expression of PPP1CB mRNA CTD PMID:21858171 NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:29,681,100...29,712,924 		JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of PPP1R15A mRNA] CTD PMID:21858171 NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:105,136,525...105,139,774 		JBrowse link
G Ppp2r1b protein phosphatase 2 scaffold subunit A beta decreases expression ISO Piroxicam results in decreased expression of PPP2R1B mRNA CTD PMID:21858171 NCBI chr 8:60,092,540...60,125,512
Ensembl chr 8:60,081,553...60,125,795 		JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PPP3CA mRNA CTD PMID:21858171 NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:227,839,062...228,113,554 		JBrowse link
G Ppp4r2 protein phosphatase 4, regulatory subunit 2 increases expression ISO Piroxicam results in increased expression of PPP4R2 mRNA CTD PMID:19192274 NCBI chr 4:135,010,919...135,051,844
Ensembl chr 4:135,010,919...135,051,844 		JBrowse link
G Prc1 protein regulator of cytokinesis 1 decreases expression ISO Piroxicam results in decreased expression of PRC1 mRNA CTD PMID:21858171 NCBI chr 1:143,659,312...143,681,019
Ensembl chr 1:143,659,481...143,681,012 		JBrowse link
G Prdm4 PR/SET domain 4 decreases expression ISO Piroxicam results in decreased expression of PRDM4 mRNA CTD PMID:21858171 NCBI chr 7:19,841,560...19,868,224
Ensembl chr 7:19,841,743...19,869,313 		JBrowse link
G Prkacb protein kinase cAMP-activated catalytic subunit beta decreases expression ISO Piroxicam results in decreased expression of PRKACB mRNA CTD PMID:21858171 NCBI chr 2:238,297,140...238,389,317
Ensembl chr 2:238,300,127...238,386,315 		JBrowse link
G Prpf18 pre-mRNA processing factor 18 decreases expression ISO Piroxicam results in decreased expression of PRPF18 mRNA CTD PMID:21858171 NCBI chr17:78,539,004...78,570,483
Ensembl chr17:78,539,839...78,600,250 		JBrowse link
G Prpf4b pre-mRNA processing factor 4B decreases expression ISO Piroxicam results in decreased expression of PRP4K mRNA CTD PMID:21858171 NCBI chr17:30,190,721...30,230,153
Ensembl chr17:30,193,907...30,225,420 		JBrowse link
G Prps1 phosphoribosyl pyrophosphate synthetase 1 decreases expression ISO Piroxicam results in decreased expression of PRPS1 mRNA CTD PMID:21858171 NCBI chr  X:108,920,663...108,942,713
Ensembl chr  X:108,920,651...108,942,711 		JBrowse link
G Psap prosaposin multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PSAP mRNA] CTD PMID:21858171 NCBI chr20:28,756,951...28,783,422
Ensembl chr20:28,757,181...28,783,421 		JBrowse link
G Psat1 phosphoserine aminotransferase 1 decreases expression ISO Piroxicam results in decreased expression of PSAT1 mRNA CTD PMID:21858171 NCBI chr 1:222,623,553...222,646,187
Ensembl chr 1:222,623,556...222,655,693 		JBrowse link
G Psma2 proteasome 20S subunit alpha 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of PSMA2 mRNA
Cisplatin promotes the reaction [Piroxicam results in decreased expression of PSMA2 mRNA] 		CTD PMID:21858171 NCBI chr17:55,250,054...55,260,441
Ensembl chr17:55,247,442...55,339,673 		JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 decreases expression ISO Piroxicam results in decreased expression of PSMC2 mRNA CTD PMID:21858171 NCBI chr 4:14,148,080...14,162,390
Ensembl chr 4:14,148,090...14,162,390 		JBrowse link
G Psmc3ip PSMC3 interacting protein increases expression ISO Piroxicam results in increased expression of PSMC3IP mRNA CTD PMID:21858171 NCBI chr10:86,524,546...86,527,764
Ensembl chr10:86,524,571...86,527,666 		JBrowse link
G Psmd12 proteasome 26S subunit, non-ATPase 12 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of PSMD12 mRNA
Cisplatin affects the reaction [Piroxicam results in decreased expression of PSMD12 mRNA] 		CTD PMID:21858171 NCBI chr10:92,937,957...92,956,601
Ensembl chr10:92,901,133...92,988,964 		JBrowse link
G Ptger4 prostaglandin E receptor 4 decreases expression ISO Piroxicam results in decreased expression of PTGER4 mRNA CTD PMID:21858171 NCBI chr 2:56,061,699...56,074,594
Ensembl chr 2:56,062,890...56,074,135 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 decreases activity EXP Piroxicam results in decreased activity of PTGS1 protein CTD PMID:9258749 NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:39,981,415...40,002,990 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
decreases activity
decreases expression 		ISO
EXP 		Piroxicam inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of PTGS2 mRNA]
Piroxicam binds to and results in decreased activity of PTGS2 protein; Piroxicam inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]
[Hydrochloric Acid co-treated with Piroxicam] results in increased expression of PTGS2 mRNA; Piroxicam promotes the reaction [L 748706 results in decreased activity of PTGS2 protein]
Piroxicam results in decreased activity of PTGS2 protein
Piroxicam results in decreased expression of PTGS2 mRNA 		CTD PMID:9258749 PMID:12925531 PMID:15309881 PMID:15878914 PMID:19147701 More... NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320 		JBrowse link
G Ptp4a1 protein tyrosine phosphatase 4A1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PTP4A1 mRNA CTD PMID:21858171 NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:40,710,250...40,718,176 		JBrowse link
G Ptp4a2 protein tyrosine phosphatase 4A2 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of PTP4A2 mRNA] CTD PMID:21858171 NCBI chr 5:142,165,405...142,192,412
Ensembl chr 5:147,449,490...147,476,738 		JBrowse link
G Ptx3 pentraxin 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of PTX3 mRNA CTD PMID:21858171 NCBI chr 2:152,797,563...152,803,372
Ensembl chr 2:152,781,955...152,803,372 		JBrowse link
G Rab1a RAB1A, member RAS oncogene family decreases expression ISO Piroxicam results in decreased expression of RAB1A mRNA CTD PMID:21858171 NCBI chr14:98,623,582...98,648,766
Ensembl chr14:98,623,635...98,661,582 		JBrowse link
G Rab2a RAB2A, member RAS oncogene family multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RAB2A mRNA CTD PMID:21858171 NCBI chr 5:26,473,424...26,537,441
Ensembl chr 5:26,473,548...26,538,488 		JBrowse link
G Rab7a RAB7A, member RAS oncogene family multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RAB7A mRNA CTD PMID:21858171 NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:121,983,938...122,064,185 		JBrowse link
G Rab8a RAB8A, member RAS oncogene family increases expression ISO Piroxicam results in increased expression of RAB8A mRNA CTD PMID:21858171 NCBI chr16:17,688,049...17,709,412
Ensembl chr16:17,688,050...17,709,477 		JBrowse link
G Rabep1 rabaptin, RAB GTPase binding effector protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RABEP1 mRNA CTD PMID:21858171 NCBI chr10:56,064,742...56,168,778
Ensembl chr10:56,064,753...56,166,177 		JBrowse link
G Racgap1 Rac GTPase-activating protein 1 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of RACGAP1 mRNA] CTD PMID:21858171 NCBI chr 7:132,629,789...132,659,738
Ensembl chr 7:132,620,595...132,659,738 		JBrowse link
G Rad1 RAD1 checkpoint DNA exonuclease decreases expression ISO Piroxicam results in decreased expression of RAD1 mRNA CTD PMID:21858171 NCBI chr 2:61,188,755...61,196,868
Ensembl chr 2:61,188,727...61,196,867 		JBrowse link
G Rad17 RAD17 checkpoint clamp loader component increases expression ISO Piroxicam results in increased expression of RAD17 mRNA CTD PMID:21858171 NCBI chr 2:33,498,335...33,528,614
Ensembl chr 2:33,498,336...33,528,144 		JBrowse link
G Rad50 RAD50 double strand break repair protein multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RAD50 mRNA] CTD PMID:21858171 NCBI chr10:38,310,147...38,362,100
Ensembl chr10:38,310,147...38,362,100 		JBrowse link
G Rad51ap1 RAD51 associated protein 1 decreases expression ISO Piroxicam results in decreased expression of RAD51AP1 mRNA CTD PMID:21858171 NCBI chr 4:161,445,610...161,458,661
Ensembl chr 4:161,445,512...161,458,680 		JBrowse link
G Ranbp1 RAN binding protein 1 decreases expression ISO Piroxicam results in decreased expression of RANBP1 mRNA CTD PMID:21858171 NCBI chr11:96,246,912...96,255,145
Ensembl chr11:96,246,740...96,255,145 		JBrowse link
G Ranbp2 RAN binding protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of RANBP2 mRNA CTD PMID:21858171 NCBI chr20:26,984,520...27,036,573
Ensembl chr20:26,985,275...27,036,571 		JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases expression ISO Piroxicam results in decreased expression of RB1 mRNA CTD PMID:21858171 NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857 		JBrowse link
G Rbbp4 RB binding protein 4, chromatin remodeling factor decreases expression ISO Piroxicam results in decreased expression of RBBP4 mRNA CTD PMID:21858171 NCBI chr 5:146,940,207...146,959,501
Ensembl chr 5:146,922,611...146,959,501 		JBrowse link
G Rbm25 RNA binding motif protein 25 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of RBM25 mRNA] CTD PMID:21858171 NCBI chr 6:108,993,119...109,050,159
Ensembl chr 6:109,002,869...109,050,159 		JBrowse link
G Rbx1 ring-box 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RBX1 mRNA CTD PMID:21858171 NCBI chr 7:114,870,893...114,881,194
Ensembl chr 7:114,870,972...114,881,191 		JBrowse link
G Rdh11 retinol dehydrogenase 11 multiple interactions ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RDH11 mRNA] CTD PMID:21858171 NCBI chr 6:103,712,373...103,728,247
Ensembl chr 6:103,712,374...103,729,741 		JBrowse link
G Recql RecQ like helicase decreases expression ISO Piroxicam results in decreased expression of RECQL mRNA CTD PMID:21858171 NCBI chr 4:177,039,351...177,063,968
Ensembl chr 4:177,035,128...177,063,838 		JBrowse link
G Reep5 receptor accessory protein 5 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of REEP5 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of REEP5 mRNA] 		CTD PMID:21858171 NCBI chr18:26,219,528...26,257,505
Ensembl chr18:26,219,530...26,250,660 		JBrowse link
G Rexo4 REX4 homolog, 3'-5' exonuclease multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of REXO4 mRNA CTD PMID:21858171 NCBI chr 3:30,678,729...30,692,376
Ensembl chr 3:30,678,740...30,689,059 		JBrowse link
G Rfc2 replication factor C subunit 2 decreases expression ISO Piroxicam results in decreased expression of RFC2 mRNA CTD PMID:21858171 NCBI chr12:27,756,920...27,770,049
Ensembl chr12:27,756,922...27,770,025 		JBrowse link
G Rfc3 replication factor C subunit 3 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of RFC3 mRNA] CTD PMID:21858171 NCBI chr12:5,836,546...5,847,331
Ensembl chr12:5,836,553...5,847,340 		JBrowse link
G Rfc5 replication factor C subunit 5 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of RFC5 mRNA] CTD PMID:21858171 NCBI chr12:44,868,322...44,877,879
Ensembl chr12:44,862,329...44,878,151 		JBrowse link
G Rgs4 regulator of G-protein signaling 4 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of RGS4 mRNA] CTD PMID:19192274 PMID:21858171 NCBI chr13:84,469,593...84,475,884
Ensembl chr13:84,469,593...84,475,884 		JBrowse link
G Rig1 RNA sensor RIG-1 decreases expression ISO Piroxicam results in decreased expression of RIGI mRNA CTD PMID:19192274 NCBI chr 5:60,117,398...60,165,995
Ensembl chr 5:60,117,398...60,165,995 		JBrowse link
G Ripk2 receptor-interacting serine-threonine kinase 2 decreases expression ISO Piroxicam results in decreased expression of RIPK2 mRNA CTD PMID:19192274 NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:34,428,573...34,459,663 		JBrowse link
G Rnaseh1 ribonuclease H1 increases expression ISO Piroxicam results in increased expression of RNASEH1 mRNA CTD PMID:21858171 NCBI chr 6:51,011,244...51,020,638
Ensembl chr 6:51,011,234...51,020,627 		JBrowse link
G Rnd3 Rho family GTPase 3 increases expression ISO Piroxicam results in increased expression of RND3 mRNA CTD PMID:21858171 NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:55,980,355...55,998,536 		JBrowse link
G Rnf139 ring finger protein 139 decreases expression ISO Piroxicam results in decreased expression of RNF139 mRNA CTD PMID:21858171 NCBI chr 7:92,329,201...92,340,386
Ensembl chr 7:92,329,157...92,341,721 		JBrowse link
G Rnf19b ring finger protein 19B decreases expression ISO Piroxicam results in decreased expression of RNF19B mRNA CTD PMID:19192274 NCBI chr 5:146,690,453...146,715,729
Ensembl chr 5:146,690,577...146,714,394 		JBrowse link
G Rpa2 replication protein A2 decreases expression ISO Piroxicam results in decreased expression of RPA2 mRNA CTD PMID:21858171 NCBI chr 5:150,260,668...150,271,329
Ensembl chr 5:150,260,723...150,271,546 		JBrowse link
G Rpia ribose 5-phosphate isomerase A decreases expression ISO Piroxicam results in decreased expression of RPIA mRNA CTD PMID:21858171 NCBI chr 4:104,282,081...104,307,732
Ensembl chr 4:104,282,081...104,307,718 		JBrowse link
G Rrm2 ribonucleotide reductase regulatory subunit M2 decreases expression ISO Piroxicam results in decreased expression of RRM2 mRNA CTD PMID:21858171 NCBI chr 6:47,044,755...47,075,370
Ensembl chr 6:47,067,690...47,075,370 		JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 decreases expression ISO Piroxicam results in decreased expression of RSAD2 mRNA CTD PMID:19192274 NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320 		JBrowse link
G Rsu1 Ras suppressor protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of RSU1 mRNA CTD PMID:21858171 NCBI chr17:81,037,848...81,286,127
Ensembl chr17:81,042,595...81,286,030 		JBrowse link
G RT1-A2 RT1 class Ia, locus A2 decreases expression ISO Piroxicam results in decreased expression of HLA-E mRNA CTD PMID:21858171 NCBI chr20:4,872,720...4,876,425 JBrowse link
G RT1-CE16 RT1 class I, locus CE16 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-A mRNA CTD PMID:21858171 NCBI chr20:3,261,656...3,265,548 JBrowse link
G RT1-DMb RT1 class II, locus DMb affects expression ISO Piroxicam affects the expression of HLA-DMB mRNA CTD PMID:25811541 NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,695,010...4,702,246 		JBrowse link
G RT1-M3-1 RT1 class Ib, locus M3, gene 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of HLA-G mRNA CTD PMID:21858171 NCBI chr20:1,329,227...1,333,394
Ensembl chr20:1,329,225...1,333,366 		JBrowse link
G Rtn3 reticulon 3 increases expression ISO Piroxicam results in increased expression of RTN3 mRNA CTD PMID:21858171 NCBI chr 1:204,612,675...204,669,212
Ensembl chr 1:214,041,838...214,109,638 		JBrowse link
G Rybp RING1 and YY1 binding protein decreases expression ISO Piroxicam results in decreased expression of RYBP mRNA CTD PMID:21858171 NCBI chr 4:134,432,663...134,484,732
Ensembl chr 4:134,432,663...134,484,930 		JBrowse link
G Sap30 Sin3A associated protein 30 decreases expression ISO Piroxicam results in decreased expression of SAP30 mRNA CTD PMID:21858171 NCBI chr16:37,758,494...37,763,825
Ensembl chr16:37,757,656...37,763,823 		JBrowse link
G Sar1a secretion associated, Ras related GTPase 1A decreases expression ISO Piroxicam results in decreased expression of SAR1A mRNA CTD PMID:21858171 NCBI chr20:30,166,310...30,178,718
Ensembl chr20:30,166,334...30,178,710 		JBrowse link
G Sars1 seryl-tRNA synthetase 1 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of SARS1 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SARS1 mRNA] 		CTD PMID:21858171 NCBI chr 2:198,753,673...198,769,411
Ensembl chr 2:198,753,675...198,769,365 		JBrowse link
G Sat1 spermidine/spermine N1-acetyl transferase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SAT1 mRNA CTD PMID:21858171 NCBI chr  X:44,008,089...44,011,376
Ensembl chr  X:44,006,781...44,011,374 		JBrowse link
G Sav1 salvador family WW domain containing protein 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SAV1 mRNA CTD PMID:21858171 NCBI chr 6:94,214,514...94,236,354
Ensembl chr 6:94,214,517...94,235,945 		JBrowse link
G Scd stearoyl-CoA desaturase decreases expression ISO Piroxicam results in decreased expression of SCD mRNA CTD PMID:21858171 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785 		JBrowse link
G Scn5a sodium voltage-gated channel alpha subunit 5 decreases activity ISO Piroxicam results in decreased activity of SCN5A protein CTD PMID:33617802 NCBI chr 8:128,098,613...128,196,515
Ensembl chr 8:128,098,613...128,196,470 		JBrowse link
G Sec31a SEC31 homolog A, COPII coat complex component multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SEC31A mRNA CTD PMID:21858171 NCBI chr14:9,518,655...9,573,579
Ensembl chr14:9,518,648...9,573,585 		JBrowse link
G Sel1l SEL1L adaptor subunit of SYVN1 ubiquitin ligase decreases expression ISO Piroxicam results in decreased expression of SEL1L mRNA CTD PMID:21858171 NCBI chr 6:116,466,163...116,510,436
Ensembl chr 6:116,466,163...116,510,578 		JBrowse link
G Selenow selenoprotein W decreases expression ISO Piroxicam results in decreased expression of SELENOW mRNA CTD PMID:21858171 NCBI chr 1:85,727,631...85,732,703
Ensembl chr 1:85,727,632...85,732,703 		JBrowse link
G Sell selectin L affects expression ISO Piroxicam affects the expression of SELL protein CTD PMID:12147693 NCBI chr13:78,950,100...78,969,604
Ensembl chr13:78,950,015...78,969,600 		JBrowse link
G Sephs1 selenophosphate synthetase 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SEPHS1 mRNA CTD PMID:21858171 NCBI chr17:78,263,725...78,296,132
Ensembl chr17:78,263,725...78,292,082 		JBrowse link
G Sertad2 SERTA domain containing 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SERTAD2 mRNA CTD PMID:21858171 NCBI chr14:98,935,428...99,039,536
Ensembl chr14:98,934,769...99,041,468 		JBrowse link
G Sesn1 sestrin 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of SESN1 mRNA CTD PMID:21858171 NCBI chr20:46,876,918...46,970,010
Ensembl chr20:46,876,895...46,970,010 		JBrowse link
G Sf3a3 splicing factor 3a, subunit 3 decreases expression ISO Piroxicam results in decreased expression of SF3A3 mRNA CTD PMID:21858171 NCBI chr 5:142,246,556...142,272,053
Ensembl chr 5:142,246,568...142,272,052 		JBrowse link
G Sh2b3 SH2B adaptor protein 3 increases expression ISO Piroxicam results in increased expression of SH2B3 mRNA CTD PMID:21858171 NCBI chr12:40,391,755...40,414,336
Ensembl chr12:40,392,633...40,414,335 		JBrowse link
G Sh3glb1 SH3 domain -containing GRB2-like endophilin B1 decreases expression ISO Piroxicam results in decreased expression of SH3GLB1 mRNA CTD PMID:21858171 NCBI chr 2:236,411,194...236,445,225
Ensembl chr 2:236,410,436...236,445,140 		JBrowse link
G Shcbp1 SHC binding and spindle associated 1 multiple interactions
increases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in increased expression of SHCBP1 mRNA] CTD PMID:21858171 NCBI chr16:91,373,843...91,405,409
Ensembl chr16:91,373,871...91,405,409 		JBrowse link
G Sinhcaf SIN3-HDAC complex associated factor multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SINHCAF mRNA CTD PMID:21858171 NCBI chr 4:181,888,301...181,913,294
Ensembl chr 4:183,619,658...183,641,626 		JBrowse link
G Siva1 SIVA1, apoptosis-inducing factor multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SIVA1 mRNA] CTD PMID:21858171 NCBI chr 6:137,526,416...137,530,790
Ensembl chr 6:137,526,031...137,530,790 		JBrowse link
G Skp1 S-phase kinase-associated protein 1 decreases expression ISO Piroxicam results in decreased expression of SKP1 mRNA CTD PMID:21858171 NCBI chr10:36,898,670...36,917,828
Ensembl chr10:36,903,078...36,918,308 		JBrowse link
G Skp2 S-phase kinase associated protein 2 decreases expression ISO Piroxicam results in decreased expression of SKP2 mRNA CTD PMID:21858171 NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:59,888,413...59,916,438 		JBrowse link
G Slc16a1 solute carrier family 16 member 1 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC16A1 mRNA] CTD PMID:21858171 NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:194,812,502...194,832,977 		JBrowse link
G Slc22a2 solute carrier family 22 member 2 decreases activity ISO Piroxicam results in decreased activity of SLC22A2 protein CTD PMID:12388633 NCBI chr 1:50,668,817...50,711,019
Ensembl chr 1:50,668,817...50,711,019 		JBrowse link
G Slc22a25 solute carrier family 22, member 25 decreases activity ISO Piroxicam results in decreased activity of SLC22A9 protein CTD PMID:12388633 NCBI chr 1:214,767,837...214,956,535
Ensembl chr 1:214,767,837...214,862,340 		JBrowse link
G Slc22a6 solute carrier family 22 member 6 decreases activity
multiple interactions 		ISO
EXP 		Piroxicam results in decreased activity of SLC22A6 protein
Piroxicam inhibits the reaction [SLC22A6 protein results in increased uptake of ochratoxin A] 		CTD PMID:10336520 PMID:12388633 NCBI chr 1:214,951,493...214,960,317
Ensembl chr 1:214,951,867...214,960,311 		JBrowse link
G Slc22a7 solute carrier family 22 member 7 decreases activity ISO Piroxicam results in decreased activity of SLC22A7 protein CTD PMID:12388633 NCBI chr 9:22,044,672...22,052,051
Ensembl chr 9:22,045,435...22,051,681 		JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions EXP Piroxicam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] CTD PMID:10224140 NCBI chr 1:214,925,506...214,945,516
Ensembl chr 1:214,925,508...214,946,588 		JBrowse link
G Slc25a12 solute carrier family 25 member 12 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SLC25A12 mRNA] CTD PMID:21858171 NCBI chr 3:76,504,868...76,599,536
Ensembl chr 3:76,504,868...76,599,536 		JBrowse link
G Slc25a13 solute carrier family 25 member 13 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of SLC25A13 mRNA] CTD PMID:21858171 NCBI chr 4:35,145,721...35,328,403
Ensembl chr 4:35,145,721...35,328,360 		JBrowse link
G Slc3a2 solute carrier family 3 member 2 decreases expression ISO Piroxicam results in decreased expression of SLC3A2 mRNA CTD PMID:21858171 NCBI chr 1:215,033,601...215,048,064
Ensembl chr 1:215,033,601...215,048,064 		JBrowse link
G Slc5a3 solute carrier family 5 member 3 increases expression ISO Piroxicam results in increased expression of SLC5A3 mRNA CTD PMID:21858171 NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157 		JBrowse link
G Slc6a15 solute carrier family 6 member 15 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SLC6A15 mRNA] CTD PMID:21858171 NCBI chr 7:40,439,607...40,493,788
Ensembl chr 7:40,439,658...40,493,786 		JBrowse link
G Slc6a8 solute carrier family 6 member 8 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SLC6A8 mRNA CTD PMID:21858171 NCBI chr  X:156,536,017...156,545,321
Ensembl chr  X:156,536,017...156,545,321 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 decreases expression ISO Piroxicam results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695 		JBrowse link
G Slc7a5 solute carrier family 7 member 5 decreases expression ISO Piroxicam results in decreased expression of SLC7A5 mRNA CTD PMID:21858171 NCBI chr19:66,843,808...66,872,412
Ensembl chr19:66,843,808...66,872,412 		JBrowse link
G Slc7a8 solute carrier family 7 member 8 increases expression ISO Piroxicam results in increased expression of SLC7A8 mRNA CTD PMID:19192274 NCBI chr15:32,153,016...32,212,715
Ensembl chr15:32,153,018...32,212,715 		JBrowse link
G Slit2 slit guidance ligand 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of SLIT2 mRNA CTD PMID:21858171 NCBI chr14:66,829,661...67,168,517
Ensembl chr14:66,829,661...67,167,146 		JBrowse link
G Smarca5 SNF2 related chromatin remodeling ATPase 5 decreases expression ISO Piroxicam results in decreased expression of SMARCA5 mRNA CTD PMID:21858171 NCBI chr19:44,172,465...44,208,967
Ensembl chr19:44,175,733...44,208,957 		JBrowse link
G Smarce1 SWI/SNF related BAF chromatin remodeling complex subunit E1 decreases expression ISO Piroxicam results in decreased expression of SMARCE1 mRNA CTD PMID:21858171 NCBI chr10:84,655,468...84,678,259
Ensembl chr10:84,655,468...84,676,185 		JBrowse link
G Smc2 structural maintenance of chromosomes 2 decreases expression ISO Piroxicam results in decreased expression of SMC2 mRNA CTD PMID:21858171 NCBI chr 5:71,592,428...71,648,636
Ensembl chr 5:71,602,308...71,648,632 		JBrowse link
G Smc3 structural maintenance of chromosomes 3 decreases expression ISO Piroxicam results in decreased expression of SMC3 mRNA CTD PMID:21858171 NCBI chr 1:262,606,731...262,649,832
Ensembl chr 1:262,607,080...262,649,825 		JBrowse link
G Sms spermine synthase decreases expression ISO Piroxicam results in decreased expression of SMS mRNA CTD PMID:19192274 NCBI chr  X:41,331,693...41,387,713
Ensembl chr  X:41,331,799...41,387,712 		JBrowse link
G Snrnp40 small nuclear ribonucleoprotein U5 subunit 40 decreases expression ISO Piroxicam results in decreased expression of SNRNP40 mRNA CTD PMID:21858171 NCBI chr 5:147,984,758...148,017,932
Ensembl chr 5:147,984,656...148,018,725 		JBrowse link
G Snrpa small nuclear ribonucleoprotein polypeptide A decreases expression ISO Piroxicam results in decreased expression of SNRPA mRNA CTD PMID:21858171 NCBI chr 1:91,609,419...91,618,119
Ensembl chr 1:91,609,420...91,618,042 		JBrowse link
G Snrpa1 small nuclear ribonucleoprotein polypeptide A' increases expression ISO Piroxicam results in increased expression of SNRPA1 mRNA CTD PMID:21858171 NCBI chr 1:129,051,492...129,065,114
Ensembl chr 1:129,048,943...129,065,114 		JBrowse link
G Snrpd1 small nuclear ribonucleoprotein D1 polypeptide multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of SNRPD1 mRNA CTD PMID:21858171 NCBI chr18:1,969,351...1,980,207
Ensembl chr18:1,969,674...1,980,207 		JBrowse link
G Snx5 sorting nexin 5 decreases expression ISO Piroxicam results in decreased expression of SNX5 mRNA CTD PMID:21858171 NCBI chr 3:152,075,258...152,094,508
Ensembl chr 3:152,075,258...152,094,877 		JBrowse link
G Sod2 superoxide dismutase 2 decreases expression ISO Piroxicam results in decreased expression of SOD2 mRNA CTD PMID:19192274 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168 		JBrowse link
G Spag5 sperm associated antigen 5 decreases expression ISO Piroxicam results in decreased expression of SPAG5 mRNA CTD PMID:21858171 NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,696,466...63,714,811 		JBrowse link
G Sparc secreted protein acidic and cysteine rich decreases expression ISO Piroxicam results in decreased expression of SPARC mRNA CTD PMID:21858171 NCBI chr10:40,017,065...40,038,816
Ensembl chr10:40,017,075...40,039,268 		JBrowse link
G Spcs2 signal peptidase complex subunit 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of SPCS2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SPCS2 mRNA] 		CTD PMID:21858171 NCBI chr 1:163,575,842...163,595,269
Ensembl chr 1:163,575,842...163,595,271 		JBrowse link
G Spdl1 spindle apparatus coiled-coil protein 1 increases expression ISO Piroxicam results in increased expression of SPDL1 mRNA CTD PMID:21858171 NCBI chr10:19,773,456...19,798,341
Ensembl chr10:19,773,457...19,798,297 		JBrowse link
G Spp1 secreted phosphoprotein 1 decreases expression ISO Piroxicam results in decreased expression of SPP1 mRNA CTD PMID:21858171 NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,613,576...5,619,820 		JBrowse link
G Sptlc2 serine palmitoyltransferase, long chain base subunit 2 decreases expression ISO Piroxicam results in decreased expression of SPTLC2 mRNA CTD PMID:21858171 NCBI chr 6:112,679,623...112,762,470
Ensembl chr 6:112,679,623...112,762,640 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SQSTM1 mRNA] CTD PMID:21858171 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750 		JBrowse link
G Srsf1 serine and arginine rich splicing factor 1 increases expression ISO Piroxicam results in increased expression of SRSF1 mRNA CTD PMID:21858171 NCBI chr10:73,335,519...73,342,549
Ensembl chr10:73,336,422...73,342,548 		JBrowse link
G Srsf10 serine and arginine rich splicing factor 10 decreases expression ISO Piroxicam results in decreased expression of SRSF10 mRNA CTD PMID:21858171 NCBI chr 5:153,372,307...153,386,520
Ensembl chr 5:153,372,316...153,386,513 		JBrowse link
G Srsf2 serine and arginine rich splicing factor 2 decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of SRSF2 mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of SRSF2 mRNA] 		CTD PMID:21858171 NCBI chr10:102,550,962...102,554,200
Ensembl chr10:102,553,072...102,554,141 		JBrowse link
G Srsf3 serine and arginine rich splicing factor 3 multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SRSF3 mRNA] CTD PMID:21858171 NCBI chr20:7,093,529...7,103,517
Ensembl chr20:7,093,565...7,103,516 		JBrowse link
G Srsf6 serine and arginine rich splicing factor 6 decreases expression ISO Piroxicam results in decreased expression of SRSF6 mRNA CTD PMID:21858171 NCBI chr 3:172,009,072...172,014,395
Ensembl chr 3:172,009,061...172,014,392 		JBrowse link
G Srsf7 serine and arginine rich splicing factor 7 decreases expression ISO Piroxicam results in decreased expression of SRSF7 mRNA CTD PMID:21858171 NCBI chr 6:20,564,035...20,571,205
Ensembl chr 6:20,564,044...20,571,212 		JBrowse link
G Ssr3 signal sequence receptor subunit 3 decreases expression ISO Piroxicam results in decreased expression of SSR3 mRNA CTD PMID:21858171 NCBI chr 2:151,915,101...151,935,162
Ensembl chr 2:151,906,149...151,935,170 		JBrowse link
G Ssx2ip SSX family member 2 interacting protein multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of SSX2IP mRNA] CTD PMID:21858171 NCBI chr 2:237,958,286...237,991,026
Ensembl chr 2:237,958,465...237,991,017 		JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of STAT3 mRNA CTD PMID:21858171 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359 		JBrowse link
G Stat4 signal transducer and activator of transcription 4 decreases expression ISO Piroxicam results in decreased expression of STAT4 mRNA CTD PMID:19192274 NCBI chr 9:56,964,617...57,080,523
Ensembl chr 9:56,911,523...57,077,346 		JBrowse link
G Stc2 stanniocalcin 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of STC2 mRNA CTD PMID:21858171 NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,755,267...16,767,447 		JBrowse link
G Stip1 stress-induced phosphoprotein 1 increases expression ISO Piroxicam results in increased expression of STIP1 mRNA CTD PMID:21858171 NCBI chr 1:213,638,641...213,657,654
Ensembl chr 1:213,638,641...213,657,654 		JBrowse link
G Stk39 serine threonine kinase 39 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of STK39 mRNA CTD PMID:21858171 NCBI chr 3:73,321,522...73,588,397
Ensembl chr 3:73,321,522...73,586,740 		JBrowse link
G Stmn1 stathmin 1 decreases expression ISO Piroxicam results in decreased expression of STMN1 mRNA CTD PMID:21858171 NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:151,964,351...151,970,842 		JBrowse link
G Sts steroid sulfatase increases expression ISO Piroxicam results in increased expression of STS mRNA CTD PMID:19192274 NCBI chr  X:46,102,524...46,110,868
Ensembl chr  X:46,102,548...46,111,104 		JBrowse link
G Sucla2 succinate-CoA ligase ADP-forming subunit beta decreases expression ISO Piroxicam results in decreased expression of SUCLA2 mRNA CTD PMID:21858171 NCBI chr15:55,161,894...55,215,031
Ensembl chr15:55,161,868...55,215,029 		JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 decreases activity ISO Piroxicam results in decreased activity of SULT1A1 protein CTD PMID:17073578 NCBI chr 1:190,702,592...190,706,112
Ensembl chr 1:190,702,592...190,706,131 		JBrowse link
G Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein increases expression ISO Piroxicam results in increased expression of SYNCRIP mRNA CTD PMID:21858171 NCBI chr 8:98,282,358...98,315,412
Ensembl chr 8:98,282,358...98,315,386 		JBrowse link
G Tcf3 transcription factor 3 decreases expression ISO Piroxicam results in decreased expression of TCF3 mRNA CTD PMID:21858171 NCBI chr 7:9,931,251...9,952,994
Ensembl chr 7:9,928,685...9,953,044 		JBrowse link
G Tdg thymine-DNA glycosylase decreases expression ISO Piroxicam results in decreased expression of TDG mRNA CTD PMID:21858171 NCBI chr 7:22,965,388...22,990,311
Ensembl chr 7:22,965,388...22,985,100 		JBrowse link
G Terf2 telomeric repeat binding factor 2 multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of TERF2 mRNA] CTD PMID:21858171 NCBI chr19:51,887,221...51,915,756
Ensembl chr19:51,887,221...51,915,566 		JBrowse link
G Tfam transcription factor A, mitochondrial decreases expression ISO Piroxicam results in decreased expression of TFAM mRNA CTD PMID:21858171 NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877 		JBrowse link
G Tgfa transforming growth factor alpha multiple interactions EXP Piroxicam promotes the reaction [Hydrochloric Acid results in increased expression of TGFA protein] CTD PMID:15309881 NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:120,175,593...120,258,339 		JBrowse link
G Tgif1 TGFB-induced factor homeobox 1 decreases expression ISO Piroxicam results in decreased expression of TGIF1 mRNA CTD PMID:21858171 NCBI chr 9:118,194,735...118,204,354
Ensembl chr 9:118,194,444...118,204,442 		JBrowse link
G Tgm2 transglutaminase 2 decreases expression ISO Piroxicam results in decreased expression of TGM2 mRNA CTD PMID:21858171 NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:167,192,612...167,304,240 		JBrowse link
G Thbs2 thrombospondin 2 increases expression ISO Piroxicam results in increased expression of THBS2 mRNA CTD PMID:19192274 NCBI chr 1:64,343,523...64,372,918
Ensembl chr 1:64,343,523...64,372,918 		JBrowse link
G Thoc2 THO complex subunit 2 increases expression ISO Piroxicam results in increased expression of THOC2 mRNA CTD PMID:21858171 NCBI chr  X:125,500,549...125,615,139
Ensembl chr  X:125,500,549...125,615,087 		JBrowse link
G Timm10 translocase of inner mitochondrial membrane 10 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TIMM10 mRNA CTD PMID:21858171 NCBI chr 3:90,315,048...90,318,613
Ensembl chr 3:90,315,092...90,318,614 		JBrowse link
G Timm13 translocase of inner mitochondrial membrane 13 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TIMM13 mRNA CTD PMID:21858171 NCBI chr 7:9,459,490...9,460,849
Ensembl chr 7:9,459,582...9,460,862 		JBrowse link
G Timm17a translocase of inner mitochondrial membrane 17A decreases expression ISO Piroxicam results in decreased expression of TIMM17A mRNA CTD PMID:21858171 NCBI chr13:49,282,918...49,296,363
Ensembl chr13:49,282,918...49,307,904 		JBrowse link
G Timm23 translocase of inner mitochondrial membrane 23 increases expression ISO Piroxicam results in increased expression of TIMM23 mRNA CTD PMID:21858171 NCBI chr16:7,416,590...7,442,681
Ensembl chr16:7,416,597...7,442,658
Ensembl chr 3:7,416,597...7,442,658
Ensembl chr 6:7,416,597...7,442,658 		JBrowse link
G Tipin timeless interacting protein multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TIPIN mRNA] CTD PMID:21858171 NCBI chr 8:73,676,020...73,696,620
Ensembl chr 8:73,676,091...73,696,620 		JBrowse link
G Tjp2 tight junction protein 2 multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of TJP2 mRNA] CTD PMID:21858171 NCBI chr 1:231,136,218...231,264,750
Ensembl chr 1:231,136,243...231,264,750 		JBrowse link
G Tk1 thymidine kinase 1 decreases expression ISO Piroxicam results in decreased expression of TK1 mRNA CTD PMID:21858171 NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,533,449...103,556,228 		JBrowse link
G Tlr2 toll-like receptor 2 decreases expression ISO Piroxicam results in decreased expression of TLR2 mRNA CTD PMID:19192274 NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194 		JBrowse link
G Tm4sf1 transmembrane 4 L six family member 1 decreases expression ISO Piroxicam results in decreased expression of TM4SF1 mRNA CTD PMID:21858171 NCBI chr 2:143,606,980...143,616,176
Ensembl chr 2:143,603,271...143,616,176 		JBrowse link
G Tmed7 transmembrane p24 trafficking protein 7 increases expression ISO Piroxicam results in increased expression of TMED7 mRNA CTD PMID:21858171 NCBI chr18:41,505,167...41,512,243
Ensembl chr18:41,478,539...41,512,243 		JBrowse link
G Tmem158 transmembrane protein 158 decreases expression ISO Piroxicam results in decreased expression of TMEM158 mRNA CTD PMID:21858171 NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:131,787,277...131,796,882 		JBrowse link
G Tmem43 transmembrane protein 43 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TMEM43 mRNA CTD PMID:21858171 NCBI chr 4:125,534,844...125,549,986
Ensembl chr 4:125,534,813...125,549,988 		JBrowse link
G Tmpo thymopoietin multiple interactions
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in increased expression of TMPO mRNA] CTD PMID:21858171 NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:27,529,978...27,554,937 		JBrowse link
G Tmx1 thioredoxin-related transmembrane protein 1 decreases expression ISO Piroxicam results in decreased expression of TMX1 mRNA CTD PMID:21858171 NCBI chr 6:94,696,699...94,707,751
Ensembl chr 6:94,696,358...94,708,618 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO Piroxicam inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
[Piroxicam co-treated with Lipopolysaccharides] results in increased secretion of TNF protein 		CTD PMID:10328874 PMID:17328244 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303 		JBrowse link
G Topbp1 DNA topoisomerase II binding protein 1 decreases expression ISO Piroxicam results in decreased expression of TOPBP1 mRNA CTD PMID:21858171 NCBI chr 8:112,766,791...112,815,203
Ensembl chr 8:112,766,508...112,810,540 		JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO Piroxicam promotes the reaction [Cisplatin results in increased expression of TP53 protein] CTD PMID:21858171 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299 		JBrowse link
G Tra2a transformer 2 alpha multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of TRA2A mRNA CTD PMID:21858171 NCBI chr 4:79,551,699...79,570,621
Ensembl chr 4:79,551,542...79,570,619 		JBrowse link
G Traf3ip2 Traf3 interacting protein 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TRAF3IP2 mRNA CTD PMID:21858171 NCBI chr20:44,565,992...44,609,240
Ensembl chr20:44,517,242...44,609,618 		JBrowse link
G Trappc4 trafficking protein particle complex subunit 4 decreases expression ISO Piroxicam results in decreased expression of TRAPPC4 mRNA CTD PMID:21858171 NCBI chr 8:53,626,382...53,630,042
Ensembl chr 8:53,625,474...53,630,241 		JBrowse link
G Trhde thyrotropin-releasing hormone degrading enzyme decreases expression
multiple interactions 		ISO Piroxicam results in decreased expression of TRHDE mRNA
Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TRHDE mRNA] 		CTD PMID:21858171 NCBI chr 7:51,829,473...52,236,843
Ensembl chr 7:51,832,111...52,236,843 		JBrowse link
G Trib3 tribbles pseudokinase 3 decreases expression ISO Piroxicam results in decreased expression of TRIB3 mRNA CTD PMID:21858171 NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802 		JBrowse link
G Trim28 tripartite motif-containing 28 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TRIM28 mRNA CTD PMID:21858171 NCBI chr 1:82,724,842...82,731,566
Ensembl chr 1:82,724,838...82,731,572 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of TSC22D1 mRNA CTD PMID:21858171 NCBI chr15:58,159,612...58,260,244
Ensembl chr15:58,159,952...58,183,322 		JBrowse link
G Tspan6 tetraspanin 6 decreases expression ISO Piroxicam results in decreased expression of TSPAN6 mRNA CTD PMID:21858171 NCBI chr  X:101,385,686...101,395,371
Ensembl chr  X:101,385,694...101,392,627 		JBrowse link
G Ttc3 tetratricopeptide repeat domain 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of TTC3 mRNA CTD PMID:21858171 NCBI chr11:47,158,766...47,258,612
Ensembl chr11:47,158,792...47,258,418 		JBrowse link
G Ttk Ttk protein kinase multiple interactions
decreases expression 		ISO Cisplatin promotes the reaction [Piroxicam results in decreased expression of TTK mRNA] CTD PMID:21858171 NCBI chr 8:93,632,678...93,672,664
Ensembl chr 8:93,634,319...93,672,664 		JBrowse link
G Tuba1a tubulin, alpha 1A decreases expression ISO Piroxicam results in decreased expression of TUBA1A mRNA CTD PMID:21858171 NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:131,968,770...131,996,035 		JBrowse link
G Txndc9 thioredoxin domain containing 9 multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNDC9 mRNA] CTD PMID:21858171 NCBI chr 9:47,707,628...47,717,761
Ensembl chr 9:47,707,231...47,880,085 		JBrowse link
G Txnip thioredoxin interacting protein multiple interactions
decreases expression
increases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of TXNIP mRNA]
Piroxicam results in increased expression of TXNIP mRNA 		CTD PMID:19192274 PMID:21858171 NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:186,781,163...186,785,731 		JBrowse link
G Ube2a ubiquitin-conjugating enzyme E2A decreases expression ISO Piroxicam results in decreased expression of UBE2A mRNA CTD PMID:21858171 NCBI chr  X:120,979,993...120,990,773
Ensembl chr  X:120,978,790...120,990,750 		JBrowse link
G Ube2b ubiquitin-conjugating enzyme E2B multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of UBE2B mRNA] CTD PMID:21858171 NCBI chr10:36,749,365...36,764,335
Ensembl chr10:36,749,369...36,765,587 		JBrowse link
G Ube2l3 ubiquitin-conjugating enzyme E2L 3 increases expression ISO Piroxicam results in increased expression of UBE2L3 mRNA CTD PMID:21858171 NCBI chr11:97,300,584...97,343,084
Ensembl chr11:97,301,945...97,343,084 		JBrowse link
G Ube2n ubiquitin-conjugating enzyme E2N multiple interactions
decreases expression 		ISO Cisplatin affects the reaction [Piroxicam results in decreased expression of UBE2N mRNA] CTD PMID:21858171 NCBI chr 7:32,041,190...32,071,252 JBrowse link
G Ubr7 ubiquitin protein ligase E3 component n-recognin 7 decreases expression ISO Piroxicam results in decreased expression of UBR7 mRNA CTD PMID:21858171 NCBI chr 6:127,663,454...127,683,302
Ensembl chr 6:127,663,447...127,694,390 		JBrowse link
G Uchl5 ubiquitin C-terminal hydrolase L5 decreases expression ISO Piroxicam results in decreased expression of UCHL5 mRNA CTD PMID:21858171 NCBI chr13:58,070,947...58,106,825
Ensembl chr13:58,042,029...58,107,441 		JBrowse link
G Ung uracil-DNA glycosylase decreases expression ISO Piroxicam results in decreased expression of UNG mRNA CTD PMID:21858171 NCBI chr12:48,145,838...48,154,789
Ensembl chr12:48,145,838...48,155,257 		JBrowse link
G Usp1 ubiquitin specific peptidase 1 decreases expression ISO Piroxicam results in decreased expression of USP1 mRNA CTD PMID:21858171 NCBI chr 5:118,703,056...118,714,426
Ensembl chr 5:118,702,868...118,714,434 		JBrowse link
G Usp16 ubiquitin specific peptidase 16 increases expression ISO Piroxicam results in increased expression of USP16 mRNA CTD PMID:21858171 NCBI chr11:40,166,651...40,196,792
Ensembl chr11:40,167,692...40,196,823 		JBrowse link
G Usp46 ubiquitin specific peptidase 46 decreases expression ISO Piroxicam results in decreased expression of USP46 mRNA CTD PMID:21858171 NCBI chr14:34,504,074...34,573,318
Ensembl chr14:34,504,118...34,573,307 		JBrowse link
G Utp11 UTP11, small subunit processome component decreases expression ISO Piroxicam results in decreased expression of UTP11 mRNA CTD PMID:21858171 NCBI chr 5:142,215,974...142,230,859
Ensembl chr 5:142,215,975...142,230,859 		JBrowse link
G Vcp valosin-containing protein decreases expression ISO Piroxicam results in decreased expression of VCP mRNA CTD PMID:21858171 NCBI chr 5:62,005,984...62,025,387
Ensembl chr 5:62,005,985...62,025,387 		JBrowse link
G Vdac3 voltage-dependent anion channel 3 decreases expression ISO Piroxicam results in decreased expression of VDAC3 mRNA CTD PMID:21858171 NCBI chr16:76,137,489...76,153,933
Ensembl chr16:76,137,504...76,155,304 		JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression ISO Piroxicam results in decreased expression of VEGFA mRNA CTD PMID:21858171 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194 		JBrowse link
G Vps28 VPS28 subunit of ESCRT-I decreases expression ISO Piroxicam results in decreased expression of VPS28 mRNA CTD PMID:21858171 NCBI chr 7:110,222,638...110,226,486
Ensembl chr 7:110,222,638...110,225,569 		JBrowse link
G Vrk1 VRK serine/threonine kinase 1 decreases expression ISO Piroxicam results in decreased expression of VRK1 mRNA CTD PMID:21858171 NCBI chr 6:130,679,400...130,746,089
Ensembl chr 6:130,679,515...130,746,752 		JBrowse link
G Vrk2 VRK serine/threonine kinase 2 decreases expression ISO Piroxicam results in decreased expression of VRK2 mRNA CTD PMID:21858171 NCBI chr14:104,514,815...104,635,549
Ensembl chr14:104,514,100...104,720,933 		JBrowse link
G Wars1 tryptophanyl-tRNA synthetase 1 decreases expression ISO Piroxicam results in decreased expression of WARS1 mRNA CTD PMID:21858171 NCBI chr 6:133,540,463...133,571,645
Ensembl chr 6:133,539,744...133,571,645 		JBrowse link
G Xpc XPC complex subunit, DNA damage recognition and repair factor multiple interactions
decreases expression 		ISO Cisplatin inhibits the reaction [Piroxicam results in decreased expression of XPC mRNA] CTD PMID:21858171 NCBI chr 4:125,550,833...125,578,084
Ensembl chr 4:125,550,833...125,578,305 		JBrowse link
G Xpot exportin for tRNA decreases expression ISO Piroxicam results in decreased expression of XPOT mRNA CTD PMID:21858171 NCBI chr 7:58,997,025...59,037,506
Ensembl chr 7:58,997,025...59,037,502 		JBrowse link
G Ybx3 Y box binding protein 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of YBX3 mRNA CTD PMID:21858171 NCBI chr 4:166,861,180...166,884,532
Ensembl chr 4:166,861,181...166,884,691 		JBrowse link
G Ywhab tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta increases expression ISO Piroxicam results in increased expression of YWHAB mRNA CTD PMID:21858171 NCBI chr 3:173,078,904...173,101,508
Ensembl chr 3:173,079,041...173,101,854 		JBrowse link
G Zfp110 zinc finger protein 110 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in decreased expression of ZNF274 mRNA CTD PMID:21858171 NCBI chr 1:82,509,563...82,533,294
Ensembl chr 1:82,517,769...82,533,292 		JBrowse link
G Zfp207 zinc finger protein 207 decreases expression ISO Piroxicam results in decreased expression of ZNF207 mRNA CTD PMID:21858171 NCBI chr10:65,883,630...65,895,895
Ensembl chr10:65,883,599...65,895,895 		JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ZFP36L2 mRNA CTD PMID:21858171 NCBI chr 6:16,242,622...16,246,662
Ensembl chr 6:16,242,610...16,246,653 		JBrowse link
G Zmat3 zinc finger, matrin type 3 multiple interactions ISO [Piroxicam co-treated with Cisplatin] results in increased expression of ZMAT3 mRNA CTD PMID:21858171 NCBI chr 2:117,034,517...117,066,141
Ensembl chr 2:117,034,517...117,065,294 		JBrowse link
G Zmpste24 zinc metallopeptidase STE24 decreases expression ISO Piroxicam results in decreased expression of ZMPSTE24 mRNA CTD PMID:21858171 NCBI chr 5:139,912,395...139,945,532
Ensembl chr 5:139,913,671...139,945,532 		JBrowse link
G Zmynd8 zinc finger, MYND-type containing 8 decreases expression ISO Piroxicam results in decreased expression of ZMYND8 mRNA CTD PMID:21858171 NCBI chr 3:174,948,162...175,061,382
Ensembl chr 3:174,948,537...175,061,571 		JBrowse link
G Zwilch zwilch kinetochore protein increases expression ISO Piroxicam results in increased expression of ZWILCH mRNA CTD PMID:21858171 NCBI chr 8:73,532,968...73,566,214
Ensembl chr 8:73,533,703...73,571,299 		JBrowse link
G Zwint ZW10 interacting kinetochore protein decreases expression ISO Piroxicam results in decreased expression of ZWINT mRNA CTD PMID:21858171 NCBI chr20:15,502,559...15,953,701
Ensembl chr20:15,937,396...15,953,203 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20862
    role 20820
      biological role 20818
        pharmacological role 19911
          analgesic 14901
            piroxicam 588
              ampiroxicam 0
              droxicam 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 20862
    subatomic particle 20860
      composite particle 20860
        hadron 20860
          baryon 20860
            nucleon 20860
              atomic nucleus 20860
                atom 20860
                  main group element atom 20781
                    p-block element atom 20781
                      carbon group element atom 20715
                        carbon atom 20710
                          organic molecular entity 20710
                            heteroorganic entity 20219
                              organochalcogen compound 19904
                                organooxygen compound 19806
                                  carbon oxoacid 19155
                                    carboxylic acid 19152
                                      carboacyl group 18085
                                        univalent carboacyl group 18085
                                          carbamoyl group 17921
                                            carboxamide 17921
                                              monocarboxylic acid amide 15953
                                                piroxicam 588
                                                  ampiroxicam 0
                                                  droxicam 0
paths to the root